<SUBMISSION>
<ACCESSION-NUMBER>0001144204-06-013358
<TYPE>6-K
<PUBLIC-DOCUMENT-COUNT>5
<PERIOD>20060403
<FILING-DATE>20060403
<DATE-OF-FILING-DATE-CHANGE>20060403
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>pSivida LTD
<CIK>0001314102
<ASSIGNED-SIC>3826
<IRS-NUMBER>000000000
<STATE-OF-INCORPORATION>C3
<FISCAL-YEAR-END>0630
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>6-K
<ACT>34
<FILE-NUMBER>000-51122
<FILM-NUMBER>06731190
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>LEVEL 12 BGC CENTRE
<STREET2>28 THE ESPLANADE
<CITY>PERTH
<STATE>C3
<ZIP>6000
<PHONE>61 8 9226 5099
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>LEVEL 12 BGC CENTRE
<STREET2>28 THE ESPLANADE
<CITY>PERTH
<STATE>C3
<ZIP>6000
</MAIL-ADDRESS>
</FILER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>v039603_6k.htm
<TEXT>
<html>
  <head>
    <title>
      Unassociated Document
</title><!-- Licensed to: Vintage Filings-->
<!-- Document Created using EDGARIZER HTML 3.0.2.1 -->
<!-- Copyright 2005 EDGARfilings, Ltd., an IEC company.-->
<!-- All rights reserved EDGARfilings.com -->
</head>
  <body bgcolor="#ffffff"><br>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><a name="return"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><strong>SECURITIES
      AND EXCHANGE COMMISSION</strong></font></a></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Washington,
      D.C. 20549</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 18pt; FONT-FAMILY: Times New Roman"><strong>FORM
      6-K</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">REPORT
      OF
      FOREIGN ISSUER</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant
      to Rule 13a-16 or 15d-16 of</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
      Securities Exchange Act of 1934</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>For
      the month of April 2006</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><strong><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Commission
      File Number 000-5112</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">2</font></strong></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><strong>pSivida
      Limited</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Translation
      of registrant&#8217;s name into English)</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Level
      12
      BGC Centre</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">28
      The
      Esplanade</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Perth
      WA
      6000</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Address
      of principal executive offices)</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Indicate
      by check mark whether the registrant files or will file annual reports under
      cover Form&#160;20-F or Form&#160;40-F). </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Form
      20-F
</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Wingdings">&#253;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Form
      40-F </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Wingdings">o</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Indicate
      by check mark if the registrant is submitting the Form 6-K in paper as permitted
      by Regulation S-T Rule 101(b)(1):</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Indicate
      by check mark if the registrant is submitting the Form 6-K in paper as permitted
      by Regulation S-T Rule 101(b)(7):</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Indicate
      by check mark whether the registrant by furnishing the information contained
      in
      this Form is also thereby furnishing the information to the Commission pursuant
      to Rule&#160;12g3-2(b) under the Securities Exchange Act of 1934.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Yes
      </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Wingdings">o</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;No
      </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Wingdings">&#253;</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If
      "Yes"
      is marked, indicate below the file number assigned to the registrant in
      connection with Rule&#160;12g3-2(b): 82- ___. </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>SIGNATURE
      </strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant
      to the requirements of the Securities Exchange Act of 1934, the registrant,
      pSivida Limited, has duly caused this report to be signed on its behalf by
      the
      undersigned, thereunto duly authorized. </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
      <table align="center" bgcolor="#ffffff" border="0" cellpadding="0" cellspacing="0" width="100%">

          <tr valign="top" bgcolor="#ffffff">
            <td width="50%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">Date:
              April 03,
              2006</font></td>
            <td width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">&#160;</font></td>
            <td width="49%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">&#160;</font></td>
          </tr>
          <tr valign="top" bgcolor="#ffffff">
            <td><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">&#160;</font></td>
            <td colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">pSivida
              Limited</font></td>
          </tr>
          <tr valign="top" bgcolor="#ffffff">
            <td><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">&#160;<br>&#160;</font></td>
            <td><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">&#160;<br>&#160;</font></td>
            <td><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">&#160;<br>&#160;</font></td>
          </tr>
          <tr valign="top" bgcolor="#ffffff">
            <td><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">&#160;</font></td>
            <td><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">By:&#160;&#160;</font></td>
            <td><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">/s/&#160;Aaron
              Finlay</font></td>
          </tr>
          <tr valign="top" bgcolor="#ffffff">
            <td colspan="2"><font style="FONT-FAMILY: " size="1">&#160;</font></td>
            <td align="left">
              <hr style="COLOR: black" align="left" noshade size="2" width="80%"><font size="2">Aaron
              Finlay</font></td>
          </tr>
          <tr valign="top" bgcolor="#ffffff">
            <td colspan="2"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">&#160;</font></td>
            <td><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: "><em>Chief
              Financial Officer and Company
              Secretary</em></font></td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 225pt; TEXT-INDENT: -18pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center">&#160;</div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong><em><u>EXHIBIT
      INDEX</u></em></strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div>
      <table cellpadding="0" cellspacing="0" width="100%">

          <tr>
            <td align="left" valign="top" width="15%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>EXHIBIT
                99.1:</strong></font></div>
            </td>
            <td align="left" valign="top" width="62%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Retisert</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><sup>TM</sup></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><em>&#160;</em></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">slows
                progression of Diabetic Retinopathy in Diabetic Macular Edema
                trials</font></div>
            </td>
          </tr>
          <tr>
            <td align="left" valign="top" width="15%">&#160;</td>
            <td align="left" valign="top" width="62%">&#160;</td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">&#160;</div>
      </div>
      <div id="PN">
        <div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ">-2-</font></div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">&#160;</div>
      </div>
    </div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>v039603_ex99-1.htm
<TEXT>
<html>
  <head>
    <title>
      Unassociated Document
</title><!-- Licensed to: Vintage Filings-->
<!-- Document Created using EDGARIZER HTML 3.0.2.1 -->
<!-- Copyright 2005 EDGARfilings, Ltd., an IEC company.-->
<!-- All rights reserved EDGARfilings.com -->
</head>
  <body bgcolor="#ffffff">
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br>&#160;</div>
    <div align="center">
      <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">

          <tr bgcolor="white">
            <td width="50%">&#160;</td>
            <td width="50%">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><img src="psivida_logo.jpg" alt=""></div>
            </td>
          </tr>
          <tr bgcolor="white">
            <td width="50%">&#160;</td>
            <td width="50%">&#160;</td>
          </tr>
          <tr bgcolor="white">
            <td width="50%"><strong><font size="2">ASX/MEDIA
              RELEASE&#160;</font></strong></td>
            <td width="50%">
              <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><strong><font size="2">&#160;3
                April
                2006</font></strong></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 18pt; FONT-FAMILY: Times New Roman"><strong>Retisert</strong></font><font style="DISPLAY: inline; FONT-SIZE: 12pt; FONT-FAMILY: Times New Roman"><sup><strong>TM</strong></sup></font><font style="DISPLAY: inline; FONT-SIZE: 18pt; FONT-FAMILY: Times New Roman"><strong><em>&#160;</em></strong></font><font style="DISPLAY: inline; FONT-SIZE: 18pt; FONT-FAMILY: Times New Roman"><strong>slows
      progression of Diabetic Retinopathy in Diabetic Macular Edema
      trials</strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Perth,
      Australia and Boston, MA - Global bio-nanotech company pSivida Limited
</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>(NASDAQ:PSDV,
      ASX:PSD, Xetra:PSI)</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      today
      announced additional two year trial results of Bausch &amp; Lomb&#8217;s two
      randomized trials to evaluate the safety and efficacy of the
      Retisert</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><sup>TM</sup></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      implant
      in releasing fluocinolone acetonide in the management of Diabetic Macular Edema
      (DME). Bausch &amp; Lomb, exclusive licensee of Retisert</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><sup>TM</sup></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      from
      pSivida conducted the studies in hospitals in the United States involving 277
      patients. The trial results were presented at the prestigious 6</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><sup>th</sup></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      International Symposium on Ocular Pharmacology and Therapeutics in Berlin that
      commenced on 30 March 2006 </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>http://www.kenes.com/isopt/index.asp</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
      two
      year trial results demonstrated that 30% of eyes receiving standard of care
      (repeat laser treatment) had a worsening of their Diabetic Retinopathy compared
      with only 10% of eyes receiving a Retisert</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><sup>TM</sup></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      implant.
      This was statistically significant. Retisert</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><sup>TM</sup></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      also
      reduced retinal thickening involving the fovea (the centre most part of the
      macula responsible for sharp, central vision) and led to a statistically
      significant three line improvement in vision. </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
        <div align="center">
          <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">

              <tr bgcolor="white" style="line-height: 1.3;">
                <td valign="top" width="60%"><font size="2">Diabetic Retinopathy
                  (DR) is the
                  leading cause of vision loss of people in the United States under
                  the age
                  of 65 with an estimated 1,000,000 treatable cases. DR occurs when
                  diabetes
                  damages the tiny blood vessels inside the retina, the light-sensitive
                  tissue at the back of the eye. DR usually affects both eyes. Currently
                  the
                  only FDA approved treatment is laser therapy in which holes are
                  burned
                  into the macula with a laser. This treatment is often ineffective
                  or
                  generally provides only temporary benefit. DME is a common complication
                  of
                  DR. There are no approved drug therapies for the treatment of either
                  DME
                  or DR. </font></td>
                <td width="40%">
                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><img src="photo.jpg" alt=""></div>
                </td>
              </tr>
              <tr bgcolor="white">
                <td width="60%">&#160;</td>
                <td width="40%">
                  <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><em><font size="2">Surgically
                    implantable Retisert<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><sup>TM</sup></font></font></em></div>
                </td>
              </tr>

          </table>
        </div>
        <div align="center">&#160;</div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8220;We
      believe the finding that sustained release fluocinolone acetonide can slow
      or
      reduce the progression of Diabetic Retinopathy is important and may have
      significant implications for Retisert</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><sup>TM</sup></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      and
      Medidur</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><sup>TM</sup></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">,&#8221;
      </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">said
      Mr
</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Gavin
      Rezos, CEO of pSivida Limited.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">pSivida
      receives royalties on Retisert&#8482; sales. Retisert&#8482; is presently priced at
      US$18,250 and is approved as a 30 month treatment for chronic non-infectious
      posterior segment uveitis, a sight threatening condition that affects an
      estimated 175,000 people in the United States and an estimated 800,000 people
      worldwide. Covered in the United States by Medicare and Medicaid, Retisert&#8482; is
      co-marketed in the United States by Bausch &amp; Lomb and Novartis.
</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Three
      year results of the Retisert&#8482; in&#160;DME&#160;trial will be presented at ARVO
      conference in May 2006 </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>www.arvo.org</u></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>-ENDS-</strong></font></div>
    <div>&#160;</div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN" style="PAGE-BREAK-AFTER: always">
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
        </div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
      <div>&#160;</div>
    </div>
    <div align="left">
      <table cellpadding="0" cellspacing="0" width="100%">

          <tr>
            <td align="justify" valign="top" width="33%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>pSivida
                Limited</strong></font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Brian
                Leedman</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Investor
                Relations</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">pSivida
                Limited</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Tel:
                + 61 8 9226 5099</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">brianl@psivida.com</font></div>
            </td>
            <td align="justify" valign="top" width="34%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>US
                Public Relations</strong></font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Beverly
                Jedynak</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">President</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Martin
                E. Janis &amp; Company, Inc</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Tel:
                +1 (312) 943 1100 ext. 12</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">bjedynak@janispr.com</font></div>
            </td>
            <td align="justify" valign="top" width="33%">
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>UK
                &amp; Europe Public</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Relations</strong></font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Mark
                Swallow / Helena Podd</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Citigate
                Dewe Rogerson</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Tel:
                +44 (0)20 7638 9571</font></div>
              <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">mark.swallow@citigatedr.co.uk</font></div>
            </td>
          </tr>

      </table>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>NOTES
      TO EDITORS: </strong></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
      <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify">
        <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left">
          <div align="center">
            <table bgcolor="white" cellpadding="0" cellspacing="0" width="100%">

                <tr bgcolor="white" style="line-height: 1.3;">
                  <td valign="top" width="60%">
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.3; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>What
                      is Diabetic Retinopathy?</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                      Diabetic Retinopathy occurs when diabetes damages the tiny
                      blood vessels
                      inside the retina, the light-sensitive tissue at the back of
                      the eye. A
                      healthy retina is necessary for good vision. Diabetic Retinopathy
                      usually
                      affects both eyes.</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.3; MARGIN-RIGHT: 0pt" align="justify"><br></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.3; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>What
                      is Diabetic Macular Edema?</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
                      Diabetic Macular Edema, a subset of diabetic retinopathy, </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">is
                      a leading cause of vision loss for Americans under the age
                      of 65. Retinal
                      blood vessels in diabetic&#8217;s eyes deteriorate and leak, causing the retina
                      to swell. A minority of cases receive long-term benefit from
                      laser
                      treatment.</font></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.3; MARGIN-RIGHT: 0pt" align="justify"><br></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.3; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>What
                      is Uveitis? </strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">An
                      autoimmune condition, uveitis manifests itself as an inflammation
                      inside
                      the eye, that can lead to sudden or gradual vision loss. </font><br></div>
                    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
                  </td>
                  <td width="40%">
                    <div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><IMG SRC="photo2.jpg"></div>
                  </td>
                </tr>

            </table>
          </div>
          <div align="center">&#160;</div>
        </div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">pSivida
      is a global bio-nanotech company committed to the biomedical sector and the
      development of drug delivery products. Retisert&#8482; is FDA approved for the
      treatment of uveitis. Vitrasert&#174; is FDA approved for the treatment of
      AIDS-related CMV Retinitis. Bausch &amp; Lomb own the registered trademarks;
      Vitrasert&#174; and Retisert&#8482;. pSivida has licensed the technologies underlying both
      of these products to Bausch &amp; Lomb. The technology underlying Medidur&#8482;, a
      treatment for diabetic macular edema, is licensed to Alimera Sciences and is
      in
      Phase III clinical trials.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">pSivida
      owns the rights to develop and commercialise a modified form of silicon
      (porosified or nano-structured silicon) known as BioSilicon&#8482;, which has
      applications in drug delivery, wound healing, orthopaedics, and tissue
      engineering. pSivida&#8217;s subsidiary, AION Diagnostics Limited is developing
      diagnostic products and the subsidiary pSiNutria is developing food technology
      products both using BioSilicon&#8482;. </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">pSivida&#8217;s
      intellectual property portfolio consists of 70 patent families, 74 granted
      patents and over 290 patent applications.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">pSivida
      conducts its operations from offices and facilities near Boston in
      Massachusetts, Malvern in the United Kingdom, Perth in Western Australia and
      Singapore. </font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">pSivida
      is listed on NASDAQ (</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>PSDV</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">),
      the
      Australian Stock Exchange (</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>PSD</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">)
      and in
      Germany on the Frankfurt Stock Exchange on the XETRA system (</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>German</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><strong>Symbol:
      PSI. Securities Code (WKN) 358705</strong></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">).
      pSivida is a founding member of the NASDAQ Health Care Index and the Merrill
      Lynch Nanotechnology Index.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The
      Company's largest shareholder and a strategic partner is QinetiQ, a leading
      international defence, security and technology company, formed in July 2001
      from
      the UK Government's Defence Evaluation &amp; Research Agency
      (DERA).&#160;QinetiQ was instrumental in discovering BioSilicon</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><sup>(TM)</sup></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      and
      pSivida enjoys a strong relationship with it having access to its cutting edge
      research and development facilities. For more information visit </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>www.QinetiQ.com</u></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">For
      more
      information, visit </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><u>www.psivida.com</u></font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This
      document contains forward-looking statements that involve risks and
      uncertainties.&#160; The statements are indicated by the use of words such as
      "believes", "expects", "anticipates" and similar words and phrases.&#160;
Although we believe that the expectations reflected in such forward-looking
      statements are reasonable at this time, we can give no assurance that such
      expectations will prove to be correct. Given these uncertainties, readers are
      cautioned not to place undue reliance on such forward-looking statements. Actual
      results could differ materially from those anticipated in these forward-looking
      statements due to many important factors including: the failure of the results
      of the Retisert for DME trial to be a good indicator </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">of
      the
      results of pSivida&#8217;s ongoing Phase III</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      Medidur&#8482;
for DME trial; failure of </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the
      Medidur</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8482;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      trials
      in DME to show a very similar improvement in visual acuity and diabetic
      retinopathy severity score as Retisert</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#8482;</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      for
      DME</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">;
      inability to recruit patients for the </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Phase
      III</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      Medidur&#8482;
for DME trial; our failure to develop applications for BioSilicon</font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><sup>TM</sup></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
      due to
      regulatory, scientific or other issues, our inability to successfully integrate
      CDS&#8217; operations and employees; the failure of the CDS&#8217; products to achieve
      expected revenues and the combined entity&#8217;s inability to develop existing or
      proposed products; the failure of the Bausch &amp; Lomb/Novartis co-promotion
      arrangement to provide faster royalty growth; failure of the slower progression
      or reduction of diabetic retinopathy resulting from the Retisert&#8482; implant to
      have significant implications for Retisert&#8482; and Medidur&#8482;. Other reasons are
      contained in cautionary statements in the Registration Statement on Form 20-F
      filed with the U.S. Securities and Exchange Commission, including, without
      limitation, under Item 3.D, "Risk Factors" therein. We do not undertake to
      update any oral or written forward-looking statements that may be made by or
      on
      behalf of pSivida.</font></div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="justify"><br></div>
    <div id="PGBRK" style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
      <div id="FTR">
        <div id="GLFTR" style="WIDTH: 100%" align="left">
        </div>
      </div>
      <div id="PN">
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
        </div>
        <div style="WIDTH: 100%; TEXT-ALIGN: center">
          <hr style="COLOR: black" noshade size="2">
        </div>
      </div>
      <div id="HDR">
        <div id="GLHDR" style="WIDTH: 100%" align="right">
        </div>
      </div>
    </div>
    <div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; LINE-HEIGHT: 1.25; MARGIN-RIGHT: 0pt" align="left"><br></div>
  </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>photo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 photo.jpg
M_]C_X``02D9)1@`!`@$`2`!(``#_X0ER17AI9@``34T`*@````@`!P$2``,`
M```!``$```$:``4````!````8@$;``4````!````:@$H``,````!``(```$Q
M``(````;````<@$R``(````4````C8=I``0````!````I````-````!(````
M`0```$@````!061O8F4@4&AO=&]S:&]P($-3(%=I;F1O=W,`,C`P-CHP-#HP
M,R`P,3HP,CHU-P```````Z`!``,````!``$``*`"``0````!````D*`#``0`
M```!````9``````````&`0,``P````$`!@```1H`!0````$```$>`1L`!0``
M``$```$F`2@``P````$``@```@$`!`````$```$N`@(`!`````$```@\````
M`````$@````!````2`````'_V/_@`!!*1DE&``$"`0!(`$@``/_M``Q!9&]B
M95]#30`!_^X`#D%D;V)E`&2``````?_;`(0`#`@("`D(#`D)#!$+"@L1%0\,
M#`\5&!,3%1,3&!$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`$-"PL-#@T0#@X0%`X.#A04#@X.#A01#`P,#`P1$0P,#`P,#!$,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,_\``$0@`9`"0`P$B``(1`0,1`?_=``0`
M"?_$`3\```$%`0$!`0$!``````````,``0($!08'"`D*"P$``04!`0$!`0$`
M`````````0`"`P0%!@<("0H+$``!!`$#`@0"!0<&"`4###,!``(1`P0A$C$%
M05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D
M1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F
M]C='5V=WAY>GM\?7Y_<1``("`0($!`,$!08'!P8%-0$``A$#(3$2!$%187$B
M$P4R@9$4H;%"(\%2T?`S)&+A<H*20U,58W,T\24&%J*R@P<F-<+21)-4HQ=D
M154V=&7B\K.$P]-UX_-&E*2%M)7$U.3TI;7%U>7U5F9VAI:FML;6YO8G-T=7
M9W>'EZ>WQ__:``P#`0`"$0,1`#\`\X>]X>[W'D]TWJ6?O'[TG_SCOB4RC9F7
MJ6?O'[T^^S]X_>HIP@IEOL_>/WI]]G[Q^]13@=AJDE??9^\?O3AUA,`N)\!)
M6[T?ZI9F<&VWGT*3V_.(7:=-^KG3\-H%=32X<N<`2F'(!XKA`GP?,V8N>_Z%
M5I^13OQ,]@E]5K1\"O8&8;0(#0/@%)V$QPU`(\PA[A[)X!W?%BZP&"YP/@20
MF+K/WC]Z]9SOJWTW*!]6ADG\YH`/X+G,_P#Q?M,NP[BT]FO$A$9!UT6F';5X
MC=9^\?O42ZS]X_>M7J'U?ZI@$^O22P?GLU"S2U/$EIBPW6?O'[U(/L_>/WI;
M4^U.M;2X?9^\?O1*WOWM]QY'=#`4ZQ[V_$(6BG__T/-W_P`X[XE)._\`G'?$
MIE$S+ITR=)2X71?53HC<NW[7>V:V']&T]R/SE@8]1NNKI'+W!J].Z1B,QZ&5
ML$-:("CR2H4.K)`6?)T\;'#6B!IV5ZM@[(-05IL0F`)*X8D6'X*33`\TXGY(
MH0[>R@:V_P"Q6/@F+!RDEI6XK7B"W<#R"N;ZK]2^GY3G65-./:?SF\3_`%5V
M.S\5!]8(^*5$;*\]7R;J/U3ZI@@O:WUZ_P!YG(^+5CEI!((@CD'E>S6XX(X6
M#U7ZL=/S0YQ9Z=IXL9H93A/NHP[/F\*58_2-^(6EU;H&9TQTN_2TGBQH.G]9
M9M?TV_$)P+&8O__1\X?_`#COB4R3_P"<=\2F43,R232E*2G1Z$T.ZI1/8DKT
MK#,-`[+S+HU@KZE2XZ:Q]Z]'PK-S`)464:AFQ;%V:G=U9!,`A9^.\B-QU5QK
MM(0"2%\JYU.-9:.6-)'Q5C#IQ'=(.<ZXNM<PN+R[AW[NU!>&O;M<)#N0LC(Z
M5>R3B/VLY]-VK93)$@V!Q:$5_6_>70C&0X3+@-W?>/[KIX>=5D#87!MX^DPZ
M$^;5<`TE<;Z&7]I]/(:YN2]P%3QHT+L<>JQE+6/=O<T07'O'YR9R^64R8F-<
M/5?S&&..B)7Q=/X']UE";0GA2B.4BW258:Z-U;2J]F.TS.G@5;3.;(2(2"XV
M1BL<TM<`YIY!$A<KUCZHL>_[1A#8^9-?YI7<6U"4%U8\$T6#HN-$:O\`_]+S
M:S^<=\2FE/9_..^)3*-E7E),G22DJ>:[&V#EIE=]T7J#+J6N!Y"\_"UNA]1.
M/;Z+C[7&6_%,F+"Z$J+Z11:)\0K];P0/)<_@90>`25K5/_%1;,QU=`/$1]RF
M#.BJLL)X1@XZ>"**3>DUT%P#BWCXJRTF%68X1H>$1KX3A2TV4I@_Q43/9-N`
MYT4@9XY10Q@IM8_@IDB)"CH?X)*1V,D:H!:)E6''MRA&"9\$TI#_`/_3\VL_
MG'?$IE)_\X[XE,&E1LJDZ<5N*(VDE)5HP%-K72"-"."CLQSX*Q7C'P2I:9@.
MOT;J3BP->?<W0A=7BY8<`N'IQW,<'-T(6KAYME+@VSCL4R>,[ADQ9P3PD^3V
M=5@(D%6&V%86'F!PU=SPM6NX%O*B9RW&V"49KQ\U1:_[T0/*-H(;@?)U3AY!
MU^"JBPJ37QJC:J;>X%1W'MV"!ZDB)Y4V.TU[]T;6TNX]_#E1\$[R9E#W:H)?
M_]3SXT$V.^)168_DKPQO>[XE6&8Z0@LEF:#,4^".S$\E?9CHS:4X0899BTJ\
M4>"L5XP\%:;4$1K`G"#&<I0LH'@IG':]NTC0HP`"D$[@"WC.[39;=AO`>26'
MZ+EM8?4@X@$J@]K7M+7B6GD*A8V[".YLOI\1R/ZRK9<%:AO\MS@-1GH>_=[%
MF0(!!1FW`\KF<+JK'M`)6KCY371!5<@AO@@NONT3[Q"J-ND<J8>"A:J;3'B4
M8$?[%2W]T462$04$-K<"/%0=H4,6:^:??)")*VG_U<`?9]Q^ER?!&9Z'\K\%
MP:2E#2D^A-]'^5^"(/2\_P`%YRDG!C+Z0/2_E)_T?\I>;))R'TK]'_*_!/\`
MH_Y7X+S1)!3Z9^C\TG>CM.Z=O>8B%YFDD4A[-WH?:G?9=WI_*)_DK7P=\Z;H
M[KS5)4<FYV=GE_D&^W5]AJW0.95AOS\UXLDH6R'V\><J3/*5X<DDI]V&WO*D
M(G25X.DBL+__V?_M#BQ0:&]T;W-H;W`@,RXP`#A"24T$)0``````$```````
M```````````````X0DE-`^T``````!``2`````$``0!(`````0`!.$))300F
M```````.`````````````#^````X0DE-!`T```````0```!X.$))3009````
M```$````'CA"24T#\P``````"0```````````0`X0DE-!`H```````$``#A"
M24TG$```````"@`!``````````(X0DE-`_4``````$@`+V9F``$`;&9F``8`
M``````$`+V9F``$`H9F:``8```````$`,@````$`6@````8```````$`-0``
M``$`+0````8```````$X0DE-`_@``````'```/______________________
M______\#Z`````#_____________________________`^@`````________
M_____________________P/H`````/____________________________\#
MZ```.$))300````````"``$X0DE-!`(```````0`````.$))300(```````0
M`````0```D````)``````#A"24T$'@``````!``````X0DE-!!H``````TD`
M```&``````````````!D````D`````H`50!N`'0`:0!T`&P`90!D`"T`,0``
M``$``````````````````````````0``````````````D````&0`````````
M`````````````0`````````````````````````0`````0```````&YU;&P`
M```"````!F)O=6YD<T]B:F,````!````````4F-T,0````0`````5&]P(&QO
M;F<``````````$QE9G1L;VYG``````````!"=&]M;&]N9P```&0`````4F=H
M=&QO;F<```"0````!G-L:6-E<U9L3',````!3V)J8P````$```````5S;&EC
M90```!(````'<VQI8V5)1&QO;F<`````````!V=R;W5P241L;VYG````````
M``9O<FEG:6YE;G5M````#$53;&EC94]R:6=I;@````UA=71O1V5N97)A=&5D
M`````%1Y<&5E;G5M````"D53;&EC951Y<&4`````26UG(`````9B;W5N9'-/
M8FIC`````0```````%)C=#$````$`````%1O<"!L;VYG``````````!,969T
M;&]N9P``````````0G1O;6QO;F<```!D`````%)G:'1L;VYG````D`````-U
M<FQ415A4`````0```````&YU;&Q415A4`````0```````$US9V5415A4````
M`0``````!F%L=%1A9U1%6%0````!```````.8V5L;%1E>'1)<TA434QB;V]L
M`0````AC96QL5&5X=%1%6%0````!```````):&]R>D%L:6=N96YU;0````]%
M4VQI8V5(;W)Z06QI9VX````'9&5F875L=`````EV97)T06QI9VYE;G5M````
M#T53;&EC959E<G1!;&EG;@````=D969A=6QT````"V)G0V]L;W)4>7!E96YU
M;0```!%%4VQI8V5"1T-O;&]R5'EP90````!.;VYE````"71O<$]U='-E=&QO
M;F<`````````"FQE9G1/=71S971L;VYG``````````QB;W1T;VU/=71S971L
M;VYG``````````MR:6=H=$]U='-E=&QO;F<``````#A"24T$*```````#```
M``$_\````````#A"24T$%```````!`````(X0DE-!`P`````"%@````!````
MD````&0```&P``"HP```"#P`&``!_]C_X``02D9)1@`!`@$`2`!(``#_[0`,
M061O8F5?0TT``?_N``Y!9&]B90!D@`````'_VP"$``P("`@)"`P)"0P1"PH+
M$14/#`P/%1@3$Q43$Q@1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`P!#0L+#0X-$`X.$!0.#@X4%`X.#@X4$0P,#`P,$1$,#`P,#`P1#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#/_``!$(`&0`D`,!(@`"$0$#$0'_
MW0`$``G_Q`$_```!!0$!`0$!`0`````````#``$"!`4&!P@)"@L!``$%`0$!
M`0$!``````````$``@,$!08'"`D*"Q```00!`P($`@4'!@@%`PPS`0`"$0,$
M(1(Q!4%181,B<8$R!A21H;%"(R054L%B,S1R@M%#!R624_#A\6-S-1:BLH,F
M1)-49$7"HW0V%])5XF7RLX3#TW7C\T8GE*2%M)7$U.3TI;7%U>7U5F9VAI:F
MML;6YO8W1U=G=X>7I[?'U^?W$0`"`@$"!`0#!`4&!P<&!34!``(1`R$Q$@1!
M46%Q(A,%,H&1%*&Q0B/!4M'P,R1BX7*"DD-3%6-S-/$E!A:BLH,')C7"TD23
M5*,79$55-G1EXO*SA,/3=>/S1I2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V
M)S='5V=WAY>GM\?_V@`,`P$``A$#$0`_`/.'O>'N]QY/=-ZEG[Q^])_\X[XE
M,HV9EZEG[Q^]/OL_>/WJ*<(*9;[/WC]Z??9^\?O44X'8:I)7WV?O'[TX=83`
M+B?`25N]'^J69G!MMY]"D]OSB%VG3?JYT_#:!74TN'+G`$IAR`>*X0)\'S-F
M+GO^A5:?D4[\3/8)?5:T?`KV!F&T"`T#X!2=A,<-0"/,(>X>R>`=WQ8NL!@N
M<#X$D)BZS]X_>O6<[ZM]-R@?5H9)_.:`#^"YS/\`\7[3+L.XM/9KQ(1&0==%
MIAVU>(W6?O'[U$NL_>/WK5ZA]7^J8!/KTDL'Y[-0LTM3Q):8L-UG[Q^]2#[/
MWC]Z6U/M3K6TN'V?O'[T2M[][?<>1W0P%.L>]OQ"%HI__]#S=_\`..^)23O_
M`)QWQ*91,RZ=,G24N%T7U4Z(W+M^UWMFMA_1M/<C\Y8&/4;KJZ1R]P:O3ND8
MC,>AE;!#6B`H\DJ%#JR0%GR=/&QPUH@:=E>K8.R#4%:;$)@"2N&)%A^"DTP/
M-.)^2*$.WLH&MO\`L5CX)BP<I):5N*UX@MW`\@KF^J_4OI^4YUE33CVG\YO$
M_P!5=CL_%0?6"/BE1&RO/5\FZC]4^J8(+VM]>O\`>9R/BU8Y:02"((Y!Y7LU
MN.".%@]5^K'3\T.<6>G:>+&:&4X3[J,.SYO"E6/TC?B%I=6Z!F=,=+OTM)XL
M:#I_66;7]-OQ"<"QF+__T?.'_P`X[XE,D_\`G'?$IE$S,DDTI2DIT>A-#NJ4
M3V)*]*PS#0.R\RZ-8*^I4N.FL?>O1\*S<P"5%E&H9L6Q=FIW=603`(6?CO(C
M<=5<:[2$`DA?*N=3C66CEC21\58PZ<1W2#G.N+K7,+B\NX=^[M07AKV[7"0[
MD+(R.E7LDXC]K.?3=JV4R1(-@<6A%?UOWET(QD.$RX#=WWC^ZZ>'G59`V%P;
M>/I,.A/FU7`-)7&^AE_:?3R&N;DO<!4\:-"[''JL92UCW;W-$%Q[Q^<F<OEE
M,F)C7#U7\QACCHB5\73^!_=90FT)X4HCE(MTE6&NC=6TJO9CM,SIX%6TSFR$
MB$@N-D8K'-+7`.:>01(7*]8^J+'O^T80V/F37^:5W%M0E!=6/!-%@Z+C1&K_
M`/_2\VL_G'?$II3V?SCOB4RC95Y23)TDI*GFNQM@Y:97?=%Z@RZEK@>0O/PM
M;H?43CV^BX^UQEOQ3)BPNA*B^D46B?$*_6\$#R7/X&4'@$E:U3_Q46S,=70#
MQ$?<I@SHJK+">$8..G@BBDWI-=!<`XMX^*LM)A5F.$:'A$:^$X4M-E*8/\5$
MSV3;@.=%(&>.44,8*;6/X*9(B0HZ'^"2D=C)&J`6B95AQ[<H1@F?!-*0_P#_
MT_-K/YQWQ*92?_..^)3!I4;*I.G%;BB-I)25:,!3:UT@C0C@H[,<^"L5XQ\$
MJ6F8#K]&ZDXL#7GW-T(75XN6'`+AZ<=S'!S="%JX>;92X-LX[%,GC.X9,6<$
M\)/D]G58")!5AMA6%AY@<-7<\+5KN!;RHF<MQM@E&:\?-46O^]$#RC:"&X'R
M=4X>0=?@JHL*DU\:HVJFWN!4=Q[=@@>I(B>5-CM->_=&UM+N/?PY4?!.\F90
M]VJ"7__4\^-!-COB45F/Y*\,;WN^)5AF.D(+)9F@S%/@CLQ/)7V8Z,VE.$&&
M68M*O%'@K%>,/!6FU!$:P)P@QG*4+*!X*9QVO;M(T*,``I!.X`MXSNTV6W8;
MP'DEA^BY;6'U(.(!*H/:U[2UXEIY"H6-NPCN;+Z?$<C^LJV7!6H;_+<X#49Z
M'OW>Q9D"`049MP/*YG"ZJQ[0"5JX^4UT057((;X(+K[M$^\0JC;I'*F'@H6J
MFTQXE&!'^Q4M_=%%DA$%!#:W`CQ4':%#%FOFGWR0B2MI_]7`'V?<?I<GP1F>
MA_*_!<&DI0TI/H3?1_E?@B#TO/\`!><I)P8R^D#TOY2?]'_*7FR2<A]*_1_R
MOP3_`*/^5^"\T204^F?H_-)WH[3NG;WF(A>9I)%(>S=Z'VIWV7=Z?RB?Y*U\
M'?.FZ.Z\U25')N=G9Y?Y!OMU?8:MT#F58;\_->+)*%LA]O'G*DSRE>'))*?=
MAM[RI")TE>#I(K"__]DX0DE-!"$``````%,````!`0````\`00!D`&\`8@!E
M`"``4`!H`&\`=`!O`',`:`!O`'`````2`$$`9`!O`&(`90`@`%``:`!O`'0`
M;P!S`&@`;P!P`"``0P!3`````0`X0DE-!`8```````<`!`````$!`/_A%_IH
M='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O`#P_>'!A8VME="!B96=I;CTG
M[[N_)R!I9#TG5S5-,$UP0V5H:4AZ<F53>DY48WIK8SED)S\^"CQX.GAM<&UE
M=&$@>&UL;G,Z>#TG861O8F4Z;G,Z;65T82\G('@Z>&UP=&L])UA-4"!T;V]L
M:VET(#,N,"TR."P@9G)A;65W;W)K(#$N-B<^"CQR9&8Z4D1&('AM;&YS.G)D
M9CTG:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS
M(R<@>&UL;G,Z:5@])VAT='`Z+R]N<RYA9&]B92YC;VTO:5@O,2XP+R<^"@H@
M/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70])W5U:60Z96-F834S9#<M8S)C
M92TQ,61A+6$W-6,M.#0Y9#@Q-6%C,V-C)PH@('AM;&YS.F5X:68])VAT='`Z
M+R]N<RYA9&]B92YC;VTO97AI9B\Q+C`O)SX*("`\97AI9CI#;VQO<E-P86-E
M/C$\+V5X:68Z0V]L;W)3<&%C93X*("`\97AI9CI0:7AE;%A$:6UE;G-I;VX^
M,30T/"]E>&EF.E!I>&5L6$1I;65N<VEO;CX*("`\97AI9CI0:7AE;%E$:6UE
M;G-I;VX^,3`P/"]E>&EF.E!I>&5L641I;65N<VEO;CX*(#PO<F1F.D1E<V-R
M:7!T:6]N/@H*(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2=U=6ED.F5C
M9F$U,V0W+6,R8V4M,3%D82UA-S5C+3@T.60X,35A8S-C8R<*("!X;6QN<SIP
M9&8])VAT='`Z+R]N<RYA9&]B92YC;VTO<&1F+S$N,R\G/@H@/"]R9&8Z1&5S
M8W)I<'1I;VX^"@H@/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70])W5U:60Z
M96-F834S9#<M8S)C92TQ,61A+6$W-6,M.#0Y9#@Q-6%C,V-C)PH@('AM;&YS
M.G!H;W1O<VAO<#TG:'1T<#HO+VYS+F%D;V)E+F-O;2]P:&]T;W-H;W`O,2XP
M+R<^"B`@/'!H;W1O<VAO<#I(:7-T;W)Y/CPO<&AO=&]S:&]P.DAI<W1O<GD^
M"B`\+W)D9CI$97-C<FEP=&EO;CX*"B`\<F1F.D1E<V-R:7!T:6]N(')D9CIA
M8F]U=#TG=75I9#IE8V9A-3-D-RUC,F-E+3$Q9&$M83<U8RTX-#ED.#$U86,S
M8V,G"B`@>&UL;G,Z=&EF9CTG:'1T<#HO+VYS+F%D;V)E+F-O;2]T:69F+S$N
M,"\G/@H@(#QT:69F.D]R:65N=&%T:6]N/C$\+W1I9F8Z3W)I96YT871I;VX^
M"B`@/'1I9F8Z6%)E<V]L=71I;VX^-S(O,3PO=&EF9CI84F5S;VQU=&EO;CX*
M("`\=&EF9CI94F5S;VQU=&EO;CXW,B\Q/"]T:69F.EE297-O;'5T:6]N/@H@
M(#QT:69F.E)E<V]L=71I;VY5;FET/C(\+W1I9F8Z4F5S;VQU=&EO;E5N:70^
M"B`\+W)D9CI$97-C<FEP=&EO;CX*"B`\<F1F.D1E<V-R:7!T:6]N(')D9CIA
M8F]U=#TG=75I9#IE8V9A-3-D-RUC,F-E+3$Q9&$M83<U8RTX-#ED.#$U86,S
M8V,G"B`@>&UL;G,Z>&%P/2=H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O
M)SX*("`\>&%P.D-R96%T941A=&4^,C`P-BTP-"TP,U0P,3HP,CHU-RTP-3HP
M,#PO>&%P.D-R96%T941A=&4^"B`@/'AA<#I-;V1I9GE$871E/C(P,#8M,#0M
M,#-4,#$Z,#(Z-3<M,#4Z,#`\+WAA<#I-;V1I9GE$871E/@H@(#QX87`Z365T
M861A=&%$871E/C(P,#8M,#0M,#-4,#$Z,#(Z-3<M,#4Z,#`\+WAA<#I-971A
M9&%T841A=&4^"B`@/'AA<#I#<F5A=&]R5&]O;#Y!9&]B92!0:&]T;W-H;W`@
M0U,@5VEN9&]W<SPO>&%P.D-R96%T;W)4;V]L/@H@/"]R9&8Z1&5S8W)I<'1I
M;VX^"@H@/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70])W5U:60Z96-F834S
M9#<M8S)C92TQ,61A+6$W-6,M.#0Y9#@Q-6%C,V-C)PH@('AM;&YS.GAA<$U-
M/2=H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O;6TO)SX*("`\>&%P34TZ
M1&]C=6UE;G1)1#YA9&]B93ID;V-I9#IP:&]T;W-H;W`Z96-F834S9#8M8S)C
M92TQ,61A+6$W-6,M.#0Y9#@Q-6%C,V-C/"]X87!-33I$;V-U;65N=$E$/@H@
M/"]R9&8Z1&5S8W)I<'1I;VX^"@H@/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O
M=70])W5U:60Z96-F834S9#<M8S)C92TQ,61A+6$W-6,M.#0Y9#@Q-6%C,V-C
M)PH@('AM;&YS.F1C/2=H='1P.B\O<'5R;"YO<F<O9&,O96QE;65N=',O,2XQ
M+R<^"B`@/&1C.F9O<FUA=#YI;6%G92]J<&5G/"]D8SIF;W)M870^"B`\+W)D
M9CI$97-C<FEP=&EO;CX*"CPO<F1F.E)$1CX*/"]X.GAM<&UE=&$^"B`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H\/WAP
M86-K970@96YD/2=W)S\^_^(,6$E#0U]04D]&24Q%``$!```,2$QI;F\"$```
M;6YT<E)'0B!865H@!\X``@`)``8`,0``86-S<$U31E0`````245#('-21T(`
M`````````````````/;6``$`````TRU(4"`@````````````````````````
M```````````````````````````````````````18W!R=````5`````S9&5S
M8P```80```!L=W1P=````?`````48FMP=````@0````4<EA96@```A@````4
M9UA96@```BP````48EA96@```D`````49&UN9````E0```!P9&UD9````L0`
M``"(=G5E9````TP```"&=FEE=P```]0````D;'5M:0```_@````4;65A<P``
M!`P````D=&5C:```!#`````,<E120P``!#P```@,9U120P``!#P```@,8E12
M0P``!#P```@,=&5X=`````!#;W!Y<FEG:'0@*&,I(#$Y.3@@2&5W;&5T="U0
M86-K87)D($-O;7!A;GD``&1E<V,`````````$G-21T(@245#-C$Y-C8M,BXQ
M```````````````2<U)'0B!)14,V,3DV-BTR+C$`````````````````````
M`````````````````````````````````````````````%A96B````````#S
M40`!`````1;,6%E:(`````````````````````!865H@````````;Z(``#CU
M```#D%A96B````````!BF0``MX4``!C:6%E:(````````"2@```/A```ML]D
M97-C`````````!9)14,@:'1T<#HO+W=W=RYI96,N8V@``````````````!9)
M14,@:'1T<#HO+W=W=RYI96,N8V@`````````````````````````````````
M````````````````````````````9&5S8P`````````N245#(#8Q.38V+3(N
M,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="```````````````N
M245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="
M`````````````````````````````&1E<V,`````````+%)E9F5R96YC92!6
M:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$``````````````"Q2
M969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M,BXQ````
M``````````````````````````````!V:65W```````3I/X`%%\N`!#/%``#
M[<P`!!,+``-<G@````%865H@``````!,"58`4````%<?YVUE87,`````````
M`0````````````````````````*/`````G-I9R``````0U)4(&-U<G8`````
M```$``````4`"@`/`!0`&0`>`",`*``M`#(`-P`[`$``10!*`$\`5`!9`%X`
M8P!H`&T`<@!W`'P`@0"&`(L`D`"5`)H`GP"D`*D`K@"R`+<`O`#!`,8`RP#0
M`-4`VP#@`.4`ZP#P`/8`^P$!`0<!#0$3`1D!'P$E`2L!,@$X`3X!10%,`5(!
M60%@`6<!;@%U`7P!@P&+`9(!F@&A`:D!L0&Y`<$!R0'1`=D!X0'I`?(!^@(#
M`@P"%`(=`B8"+P(X`D$"2P)4`ET"9P)Q`GH"A`*.`I@"H@*L`K8"P0++`M4"
MX`+K`O4#``,+`Q8#(0,M`S@#0P-/`UH#9@-R`WX#B@.6`Z(#K@.Z`\<#TP/@
M`^P#^00&!!,$(`0M!#L$2`15!&,$<01^!(P$F@2H!+8$Q`33!.$$\`3^!0T%
M'`4K!3H%2058!6<%=P6&!98%I@6U!<4%U07E!?8&!@86!B<&-P9(!ED&:@9[
M!HP&G0:O!L`&T0;C!O4'!P<9!RL'/0=/!V$'=`>&!YD'K`>_!]('Y0?X"`L(
M'P@R"$8(6@AN"(((E@BJ"+X(T@CG"/L)$`DE"3H)3PED"7D)CPFD";H)SPGE
M"?L*$0HG"CT*5`IJ"H$*F`JN"L4*W`KS"PL+(@LY"U$+:0N`"Y@+L`O("^$+
M^0P2#"H,0PQ<#'4,C@RG#,`,V0SS#0T-)@U`#5H-=`V.#:D-PPW>#?@.$PXN
M#DD.9`Y_#IL.M@[2#NX/"0\E#T$/7@]Z#Y8/LP_/#^P0"1`F$$,081!^$)L0
MN1#7$/41$Q$Q$4\1;1&,$:H1R1'H$@<2)A)%$F02A!*C$L,2XQ,#$R,30Q-C
M$X,3I!/%$^44!A0G%$D4:A2+%*T4SA3P%1(5-!56%7@5FQ6]%>`6`Q8F%DD6
M;!:/%K(6UA;Z%QT701=E%XD7KA?2%_<8&QA`&&48BABO&-48^AD@&449:QF1
M&;<9W1H$&BH:41IW&IX:Q1KL&Q0;.QMC&XH;LAO:'`(<*AQ2''L<HQS,'/4=
M'AU''7`=F1W#'>P>%AY`'FH>E!Z^'ND?$Q\^'VD?E!^_'^H@%2!!(&P@F"#$
M(/`A'"%((74AH2'.(?LB)R)5(H(BKR+=(PHC."-F(Y0CPB/P)!\D321\)*LD
MVB4))3@E:"67)<<E]R8G)E<FAR:W)N@G&"=))WHGJR?<*`TH/RAQ**(HU"D&
M*3@I:RF=*=`J`BHU*F@JFRK/*P(K-BMI*YTKT2P%+#DL;BRB+-<M#"U!+78M
MJRWA+A8N3"Z"+K<N[B\D+UHOD2_'+_XP-3!L,*0PVS$2,4HQ@C&Z,?(R*C)C
M,ILRU#,-,T8S?S.X,_$T*S1E-)XTV#43-4TUAS7"-?TV-S9R-JXVZ3<D-V`W
MG#?7.!0X4#B,.,@Y!3E".7\YO#GY.C8Z=#JR.N\[+3MK.ZH[Z#PG/&4\I#SC
M/2(]83VA/>`^(#Y@/J`^X#\A/V$_HC_B0"-`9$"F0.=!*4%J0:Q![D(P0G)"
MM4+W0SI#?4/`1`-$1T2*1,Y%$D5519I%WD8B1F=&JT;P1S5'>T?`2`5(2TB1
M2-=)'4EC2:E)\$HW2GU*Q$L,2U-+FDOB3"I,<DRZ30)-2DV33=Q.)4YN3K=/
M`$])3Y-/W5`G4'%0NU$&45!1FU'F4C%2?%+'4Q-37U.J4_940E2/5-M5*%5U
M5<)6#U9<5JE6]U=$5Y)7X%@O6'U8RUD:66E9N%H'6E9:IEKU6T5;E5OE7#5<
MAES672==>%W)7AI>;%Z]7P]?85^S8`5@5V"J8/QA3V&B8?5B26*<8O!C0V.7
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MRHTQC9B-_XYFCLZ/-H^>D`:0;I#6D3^1J)(1DGJ2XY--D[:4()2*E/257Y7)
MEC26GY<*EW67X)A,F+B9))F0F?R::)K5FT*;KYP<G(F<]YUDG=*>0)ZNGQV?
MBY_ZH&F@V*%'H;:B)J*6HP:C=J/FI%:DQZ4XI:FF&J:+IOVG;J?@J%*HQ*DW
MJ:FJ'*J/JP*K=:OIK%RLT*U$K;BN+:ZAKQ:OB[``L'6PZK%@L=:R2[+"LSBS
MKK0EM)RU$[6*M@&V>;;PMVBWX+A9N-&Y2KG"NCNZM;LNNZ>\(;R;O16]C[X*
MOH2^_[]ZO_7`<,#LP6?!X\)?PMO#6,/4Q%'$SL5+Q<C&1L;#QT''O\@]R+S)
M.LFYRCC*M\LVR[;,-<RUS37-M<XVSK;/-\^XT#G0NM$\T;[2/]+!TT33QM1)
MU,O53M71UE76V-=<U^#89-CHV6S9\=IVVOO;@-P%W(K=$-V6WAS>HM\IWZ_@
M-N"]X43AS.)3XMOC8^/KY'/D_.6$Y@WFEN<?YZGH,NB\Z4;IT.I;ZN7K<.O[
M[(;M$>V<[BCNM.]`[\SP6/#E\7+Q__*,\QGSI_0T],+U4/7>]FWV^_>*^!GX
MJ/DX^<?Z5_KG^W?\!_R8_2G]NOY+_MS_;?___^X`#D%D;V)E`&0``````?_;
M`(0`!@0$!`4$!@4%!@D&!08)"P@&!@@+#`H*"PH*#!`,#`P,#`P0#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`$'!P<-#`T8$!`8%`X.#A04#@X.#A01
M#`P,#`P1$0P,#`P,#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,_\``
M$0@`9`"0`P$1``(1`0,1`?_=``0`$O_$`:(````'`0$!`0$```````````0%
M`P(&`0`'"`D*"P$``@(#`0$!`0$``````````0`"`P0%!@<("0H+$``"`0,#
M`@0"!@<#!`(&`G,!`@,1!``%(1(Q05$&$V$B<8$4,I&A!Q6Q0B/!4M'A,Q9B
M\"1R@O$E0S13DJ*R8W/"-40GDZ.S-A=49'3#TN(()H,)"A@9A)1%1J2T5M-5
M*!KRX_/$U.3T976%E:6UQ=7E]69VAI:FML;6YO8W1U=G=X>7I[?'U^?W.$A8
M:'B(F*BXR-CH^"DY25EI>8F9J;G)V>GY*CI*6FIZBIJJNLK:ZOH1``("`0(#
M!04$!08$"`,#;0$``A$#!"$2,4$%41-A(@9Q@9$RH;'P%,'1X2-"%5)B<O$S
M)#1#@A:24R6B8[+"!W/2->)$@Q=4DP@)"A@9)C9%&B=D=%4W\J.SPR@IT^/S
MA)2DM,34Y/1E=865I;7%U>7U1E9F=H:6IK;&UN;V1U=G=X>7I[?'U^?W.$A8
M:'B(F*BXR-CH^#E)66EYB9FIN<G9Z?DJ.DI::GJ*FJJZRMKJ^O_:``P#`0`"
M$0,1`#\`\XS3SB>0>HWVCW/CF.Y(6B>X_P!^/_P1Q2N$\_\`OU_O.*5PGG_W
MXWWG`J[UY_\`?C?><":;$\_^_&^\XVK?K3_[\;[SBK:R7#-Q1W9OY5))_#&U
M1D6F:],`8K:Y<>(5\%IX6YM*UZ%>4MM<HH[E6PVCA0+/.IHSNK#L20?QPVBE
MI>X_WXW_``1PV@A87G_WXW_!'#;&EIDN/]^-]YP@H(:$EQ_OQ_O.&V-+UEN/
M]^-]YQM%*JS3_P"_&^\X+6E>VFG]:,>HWVAW/CBM/__0\W3_`-_)_K']>8[E
M-`8I7`8JN`P%5P&!*Y5)-!N3T&!+/O*'Y2:QK02YO6^IV;;A2/WC#Y=LIGF$
M=N9;(XR7L_EO\N-`TJ-5M[5&<#>5U#,?OR@SE)NH!E<.C1*`%10.U`!@X5XU
M\FBQ.I#JK#P8`C#PKQL>UO\`+?RWJ0/UFRBYM_NQ%"M^%,D#(=4;'H\ZUW\@
M(R'DTJ\,;=1%**K\JC+!F[PP.(="\UU_\O\`S1HA)O+-GA'^[HOC7\.F71F#
MR:I0(YL=,>2MA2WT\-L:;">V-HI<%PVBE:W'[^/_`%A^O%:?_]'S?/\`W\O^
ML?UYCN4T!@2N`Q5<,"5P&!(>C?E5Y(35+D:I>I6VA;]PAZ,P_:^C*,V3AV'-
MMQPO=]":=IZI&M!0=!F,(MQDG5O"H&VWB<L`:B46L7AN>XR00YX3VVPD)"B8
MMJ4R+)2:VB/??N,5M!7>E1RH5*!T/4$`C!3(2>;^:OR7\OZF\EQ;QM8W3[\X
M_L$^ZY8,I'/=B<<3R>4^8ORG\T:,#*D8OK<=9(?M#YKED<@+5+&0PYHF5BK`
MJP-"I%"#D[:Z;"XVM*D`_?Q_ZP_7AMB0_P#_TO.$_P#?R?ZQ_7F,Y8:&!5PQ
M2N&*HBPM7N[V"U3[4SA!])P$TD/IORCI4-C8P01*%2-0`/HS7DV;<V(H,WM1
M4`=-N@R8:R$UCH%H-R.N64UJR'@NW4]3BM+@"=^W<G%5.@Z#K@2TT(Z_?AI(
M+0@VV/7MAI5*:V5DW'7L<>%0E-UIRD'84[Y`Q;1)@GFO\L?+^KK([P""Y;I<
M1?"P/N!UPB9"#C!>*^;/(6L>77Y2#ZS9L3QN(U.W^MX9;&0ER:)P,>;'8*>O
M'3^8?KR5M9#_`/_3\XS?W\G^L?UYC%RUHP)7`XJWBJ?^1HED\TV0;HK%ONR&
M3Z2SQ_4^E-(:B!3NNV8#GLEM)!L1VVRX-1"9*Y`!!K7)-=*6IWLEIIUQ=+NT
M*%D'OE>61C$GN;,./BF!WH_2+/27\H-K#WA>ZEA,C3%Q\,F]%"_/#C$?!XR=
MZ:\LI^-P5M:6:-KMM?*(GD5+U15XB:$@]"OB#E.'41EM_$WYM/*&_P#"G*C:
MOWYE!QFRHK7QZ4R2VM!5B:K]_CA0IR6Z,2*5&"DVE\^GH0]01X'(&+,32'4-
M*ADC:.15=&V*D5!'R.5D4W`V\K\X?E'#-,;[1U]&<,&:W&R-OV\,LADZ%IGB
MZQ?_U/.$Y_TB7_6/Z\QG*6@XI;K@I6ZX:5.O)MP(/,EFY-`6*U^>0R"XEGC/
MJ?2&BW!>%17ML<PJ<\%D5A.P`#GXCU.38D)S%)\``/?"U%5F1)8_3<<D>H8'
MH01B1:Q-&V)W_E2_B!.F3A(?M?5Y*E.5>WAF#ETTJ]+M,.K@3ZQO_.8O]2U8
MZGZ%\DD>I2R*MK.IH@'SS3Y<<N*C];M^/'P7&O#`]3V+3[6XALHH99#-+&O%
MI6V+4_:SIL$#&`!-EY/)(&1(V"L``/BVRVF#;)L#U'0XTBUM*]>OCBFUKQA@
M?#%04JN;52Q(&PZY60VB2#DMU(`H*UR-)M__U?-TY_TB7_6/Z\QW)65Q3;=<
M57#%5:VF:"XCG7[4;!A]&`I>^^2_,$%W:1.K=1OF'.-%S82L,[L+M201N#UR
M#:1LR"VF5@.P&3:2BQ*`./<],*`%92&HI^6&DJ@M8I*.Z*[)]FHKO@.,'F%X
MR.28QN>)W_VJY<TES$$C85'4=CBH6$,`:=^V!5I1J=*X"MK:M0BM#W'],"5&
MXAJ*G_,8D,HE`M&.0(]L@S?_UO-D_P#O1)_K']>8[DK1BJX8II<,4KA@5EOD
M;S"]A<_57:D;FL9\#X97.-MD)T7MN@ZHDJ*Q.YS&(<P%EUM/3H:\L"IA%<.U
M*'WPVQI&I(:#P[Y)",AE!&QZ;G)!@5=)J5_'^S)`L2%;U`*5V.2M%+@]=QU[
M@^.**;9AQJNWM[_[>`K2F:$GVZ'`E1D;:@^(=QWP)"&-&<$[`;9%D7__U_-L
MX_TB7_6/Z\QW)6@8I7#%6P,"KU&*5:))`P931@:@CQQ6WIODWS)*T2)*?WB;
M,I[^^59,?5MQ9>A>JZ7JZNJU(W`S'(<L;L@M9U(Y`[^&`*4Q2=B-Z>^284KQ
M3CEX85(1D<R_)NE=L(8TO$]2`Q]_?;)6M+Q,0U#\JC&T4K>HIKOMU^[;),5G
M-JDC>@.V15#NQ^T:D@"O\<#.EG6F]17?`A__T/-TW^]$O^L?UYCN2X(Q[8K:
MHMNY[8TMJT=FY[8:8F:,AT\FFV'A8'(F-OIA/[.'A:I94TL]/>)UD0%6'?)"
M#2<S*M(UJXM9%CG)"G[+=LQLN&G9Z75">W5G>CZRKC>3KT&8I#L`;97!>*R"
MAJ<;8UNB(IJ]#OX8I*($Y'?&T4K)<GKUIDK6E6.<C>OT8;8D+_7++QKN34C#
M:TKPR;$'HQW/RZ86!#4KDFM.^P\1@*A0,GQ]^HK[8&5/_]'S\UB3/)M^T?UY
M3PMAFBH=./\`+DN%K.5&PZ633X<(BU2S(V'2NGPY,0:CF3"#2P*?#DA!JEE3
M&#3@/V<D(M1RH^*Q%.F3$6LY$0VGQRQE''PGN.H^6$X["QS&)L(>&ZO-)F"2
ML3$3^[D[$>!S79L!!=_I-:)CS9GHWF-)"@9O#,0Q=G$LEAOP0&5O]K(-@%HZ
M*\#'XCOA1PHOU"%!\<6(7>LM*]QVPK2I#,"=S0G$*0C%=-MZ#P\?;)AK*KS#
M#Q&$L5&39AX^/;(%+__2Y(NG?OGV_:/Z\D(.'+*CH-.'ADQ!I.5'Q6'3)<+4
M<B+CL@.V2$6LY$5';`=LEPL#-$I"HR0BQXE95`PTBU08:1;4L<<T;1RJ&1A0
M@Y&4013*,B#82&XBO=(?U$K+9UV8?:3_`%LUV;3T[[1]H"6QYL@T7S5%+$%9
MLPI0IW4,ELKL-4CD"E7RLAOXK3J.[#*!7;(L:5EF4[@[XII7]4[']6%42MR"
MM1\LD"PI66XH>N_^?ZL-L"%YGJ5)WWR)+&G_TX"OU#U6KZE>1\/',@.HDC8?
MJ/\`E_ADVLHN/ZGVY_AA:RB%^J?Y?X9(,50?5?\`+_#)(7#ZMVY_ABNRX?5_
M\O\`#%.R\?5_\O\`#`C9L?5_\O\`#%.SG^J>FWJ<O3I\?*E*>^1/+=D.>S#)
M/J/Z3D_1GJ?5J[]./+OQ]LUF;AO9Z/1>)P[LNT/UJCCZE.]:4S$E3M(VS"UY
MT7[5?HRHTW"T?'VIRZ[].N!L"+2E-^7MTQ8*L77;E^&$+)%)P_:KAV:C:]:5
+%.5=O#I[8-D%_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>photo2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 photo2.jpg
M_]C_X``02D9)1@`!`@$`2`!(``#_X19L17AI9@``34T`*@````@`!P$2``,`
M```!``$```$:``4````!````8@$;``4````!````:@$H``,````!``(```$Q
M``(````;````<@$R``(````4````C8=I``0````!````I````-````!(````
M`0```$@````!061O8F4@4&AO=&]S:&]P($-3(%=I;F1O=W,`,C`P-CHP-#HP
M,R`P,3HS,SHU,0```````Z`!``,````!__\``*`"``0````!```!#:`#``0`
M```!````S0`````````&`0,``P````$`!@```1H`!0````$```$>`1L`!0``
M``$```$F`2@``P````$``@```@$`!`````$```$N`@(`!`````$``!4V````
M`````$@````!````2`````'_V/_@`!!*1DE&``$"`0!(`$@``/_M``Q!9&]B
M95]#30`#_^X`#D%D;V)E`&2``````?_;`(0`#`@("`D(#`D)#!$+"@L1%0\,
M#`\5&!,3%1,3&!$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`$-"PL-#@T0#@X0%`X.#A04#@X.#A01#`P,#`P1$0P,#`P,#!$,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,_\``$0@`>@"@`P$B``(1`0,1`?_=``0`
M"O_$`3\```$%`0$!`0$!``````````,``0($!08'"`D*"P$``04!`0$!`0$`
M`````````0`"`P0%!@<("0H+$``!!`$#`@0"!0<&"`4###,!``(1`P0A$C$%
M05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D
M1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F
M]C='5V=WAY>GM\?7Y_<1``("`0($!`,$!08'!P8%-0$``A$#(3$2!$%187$B
M$P4R@9$4H;%"(\%2T?`S)&+A<H*20U,58W,T\24&%J*R@P<F-<+21)-4HQ=D
M154V=&7B\K.$P]-UX_-&E*2%M)7$U.3TI;7%U>7U5F9VAI:FML;6YO8G-T=7
M9W>'EZ>WQ__:``P#`0`"$0,1`#\`]38QE;&L8T,8P!K6M$``:!K0%))))2E&
MQQ96Y[6E[F@D,;$N('T6[MK?<I))*<FGZR].NLH:`]K<EM9J>6Z;K:_M7I.:
MV7L]+'=5;?:]OH5>M3^D_2(C?K'T1S99EL>=K'AC`YSRVP;V;*6-=;9^C<VQ
MVQGZ.K])9^C4QT/I;=NVC:6V6V@M<YIWWN]7)=N:[=^E?^;_`*/]%_-*#_J_
MTLESZZC5:8+;&/L:YKFL%`LK=78QS'^BUM5KF?SU?\ZDI*>M=*!I'VJMQR'!
ME.UV[>XE[/9LW;O=59[DLGK72\6U].1D-KLK:'.:9[EH#-![K?TM7Z!OZ;]+
M5^C_`$BS^G]$Z1DXKF6XS665N%.30Q]C:FOI)=%-/J;:Z'OL^U5L_/\`6]:S
M]*K-_P!7\+(SWYEY>\/`(H!VL%K?2VY;?3VO^U-;CTULNW[V5^Q)3:P.HXW4
M&VV8KO4JK>&-M!!:_=77>'UN:3N9MOV_UU:0,/!Q<*MU>,STVN(<X23)#6U;
MBYY<[Z%;$V6W)V%^,1ZHX:=0?)S26_\`5UI*;"2Y[_G!D,M&/8QM&9R,9Y)#
MQ^;Z3G-98US_`/7U%<Z7]8L'J-IQA-&6V9HLY.W1_I._PFQP]_\`A&?GUI*=
M5))))2DDDDE*22224I))))3_`/_0]525#K69D8>%ZV/M:396Q]U@+F5,>X,M
MR;6,<QSJZ6_R]C/YRY]='JV+'9]:\OTG5_9V79#6O<'L+FM+&BVRG/NHV768
MO3<FFCV7>I?9Z]M=/IVU_K"2GITEBX_UA?97F.=CF<.@W>F"1:_:WU/YC86U
MU7SMQ;/7_3_I?T?Z)`L^M.33;919TVSU:J['N#'RTN8;6?H7.KK?;3^AVOO]
M/]%9?3^B24]"DN>R?K5?C/%;^FW/L;8:+&L=IZC=A=7COM95]HWTWTY&/_->
MM3]H_F[<6RI;E^13CU^I<[:V0!`+B2?HL8QFY[WN_<8DIJ6D8/4A>3MQLX!E
MI.@;>P?HK7'\WUZ&^@][OSZ,2O\`PB;(ZNQNT4@'U#%=CYAY_P"ZU+-UV5^]
M[-E'_=A9_5,DY5;V7/%`;[N1MQ@/<W.RW3Z-E]%C&NHQMVRN[_2?X/*RL]C<
M<.RW.#KVC<UI(R+P#VM]K\/IECO?M?\`K>35^C_14I*=>WJ=UI>S>]UC!#ZF
M2W88]KKFT.<ZC_B\CJ-']A9]_5**],BRJU^D[_3)D?R8ZC_Y]6%F=1NRVMI:
MQM&+7I717HP#X#Z3_P"6JH:DIV;\_I.4`W*Q\;(:!`WLJD3^[NPZO_/K%8Z>
M_H+0^HM=36XMV[W.<P.'T2W)-^3;C/;_`(+T\W'_`.*6`&%.*GM=OK):X=QH
MDI]$Q;',J#\;(.=C\07-<\1H=ES-OJ[?SV6_I?\`A?\`!JY5;7:W=6X.`,'Q
M!_=<W\U_\ERX+H?5W8&0XV`,8\-]<-$#:T_TMK&_X6AKG_:6?X?&_P"(8NS<
MXNL%M0`R6C5D^VUG,;O_`#T__!_\78DINI*%5C;6![.#X\@C1S7?RFN^D@]0
MS#B4`UM]7(M<*L:KC?8X$M:3KMK:UKK;G_X.BNVU)32ZMGYGNQ^D`W9F,6V7
ML`&W:YKW5TV/LVMW6NV>RIWK,J]_Z+U*D/#R^O#J->-E4!V.XV;[FL(T#K]E
MNXV.KKJ?LQ_2IW6Y/Z7_``C-^15HX&&,/&%.[U+"7676Q&^QY-EUFWW;=UCO
M:S_!L_1JRDI22222G__1]540U@<2``YVKB.3&FJDJ^33<YN['>&O'YK_`*+O
MFWWU_P#&,24SM=97[FM+V]P.1\%3?U"MX=Z#G/\`3CU&U^ZQD\/],_SM7^M:
M!7U6UCC7<Q^]ABRJ`;F"?YST_P#M5C?\/1^E_P""L0<[I]>38SJ&'<<:]P(;
MFXP%C".=N3CGVV5._P!)2]EO\NM)3H4]5H-377G8XB0YH<YCQ^]0YN[=_P`5
M_/,5.]^3?DM>`^NTF:V@#?71K]!MGZ+[;FV,<W])_,8OT_2].WU*G0[<S[3U
M&S)M;7C4N9N<R&T.L]S[;Z;?ZGI^O7L_G/\`2V?I7CZSD,9CN:2\.SFAUS9A
MPH8T,>YNH?6[*=Z>+O?[_3]5)31ZGU!@AU9#JJR!BM'N:^UA+;,WW_SM&/\`
MS.%ZG\Y?ZV9^E_1VK$<Y]MCWVDO?82_<[4EP^EK_`"Z__/2-8Y]UAL?H8`:T
M<-:/:RMO\EC4[*9X)!Y#AR"-6N_LI*0-KG@?-'KH)5C':RQQ$M-C?YP-X!ES
M>!]#?L]1G\A7:\8<PDIHLQO)$&-Y+2;CA3^S#XI*<:W&<',>P>]KAL^)*Z/H
MCMO36ORK655T6!M#G.$MJ<6LQ-^OMW./I5[_`.=J]-4[<8;#&A['S58Y>3TV
MF^K$/HNRW^H+6ANYMH;#?YSV.8^QE'J5[/YC[1^?Z:2GH\;/QWL=G5D5UE[Z
M\QA<TAME?M?9O:[TW>DVO]+L_P`#_P`2GZ?5;DY#^J9,@/!;@TN$&ND[9>[_
M`(;+<QMS]_OIK].C_2KFC6/M%MV`UOZ=E5V51)%=FX,N;BY%;?\`"?F6?]U?
M1_GF9%E:Z"OJ3::*'8M;\AN8/U7&;]-CA_.UVV']'71CN_G?=^@_FJJ[?96D
MIUU2QNL=-RFN?5>-@+`'O#JVN]4[<=]+KFUMOJR'?T>ZGU*K_P#!*->'FW/;
M9G9$-!#ABX\MKD=K;C^GR?\`V7IM_P`+C*J[ZL8K\9F*_*R7TU0VAI<R*Z@R
MS&^S,'I;=CL>^VEU]GJ9W_=M)3I?;\'U/2^T5>H-Q+-[=T5G;=[9_P`$[^<_
M<4J\K&L>&5W,>\M%@:UP)+'?1L@'^;=^^LR[ZJ])NI-+FO:P[?HD`^UM];/=
MM_[N7._E_P"$_P`)ZC8OU6Z=BY^-GL?:;<-KV4M):&#U6M9>=C*V?SGI^KM9
M^C]7\Q)3_]+U5)4^K]0_9G3K\[TG9'H`'T:XWNDAFQF[\_W+/_YW=,:^SU=S
M*66^FW($/8YFVES,K]&3MQ[+<CTJG_\`7?YM)3K9&)C930W(K;8&ZMW#5I_>
M8[Z3'?RF+*RNBYE1=;TW(<VQVK@YVUQ^-FU]=W_H53;9_P`.CNZ_B"@V>G:V
MUIVFBQI8\.VBW:_=[&_H7>K])%PNM]-S6/=5:&;+'5%MD,)<UK+?9N_G&NIN
MJM]G^D24YV'GB[I]EW5!#L:X49-.T0][2U['>D-_YMGJ65L_/_D+$ZMBMJR;
M:ZV"MIL#WAH@.L=5398YT?R['?YZZ/+K95D665-G??3<_0.:7/8[#W]MOT*]
MVU8'7*B.KT7`N'J7LQK&R8<VW':ZF:_H>HW)K9LM_G/\&DII5T$G56Z<<?)%
MJQYUX^'BKU6.#`*2FKB]-IKOLR&,#7W!HM+=`[;.RQP_TFUVW>K]>-]R-54&
MZ;?CX>*L-#>WW!)37;C@*7HJRUH/&B?8$E-4TM(.XPV#N=X#N4^-T_&MHWY5
M3+?M+1N:]H(94[Z-#-WT?WW_`)_J?U&*>8-N)<1I[")_K>S_`+\KCP![1H`(
M`^"2G`PP*&4T?FX-]F&^22342TT/=_5]1C/[:T1C^A835[6Y#@'`_1;</=CW
M1_*<STK?])^B6)U"UN-UO,:YX%5_NV$F`]HQK66[6_UOTG_%T+<MZCA.:?TA
MT>QPFNS\U[7_`.C\DE.G58+*V6`0'@.@]I"FL^CJF$VO:7NT<X"*[#IN=M_P
M?[J>[K.(RFRQFY[JV/>&%CV`[&NL@V/9L9]'Z3DE-])<[B_6ZH5-_:6.[&ML
MK%U(;,65EV-1N97DMQLEKOM&9Z.Q]'Z3TO5K_G*U8Q/K-3EYM&+526FYP:\/
M<W<PFN_);_,.OHNW,QV_S5_^$_TE7II*?__3]3?6RQNVQH>V08<)$@[FG7]U
MP5<=,Z:"TC$I!8&AI%;=`S::P/;_`(/TV>G^XK222FI7TKI=1!KPZ&$-+`6U
ML'M)W.9HWZ+G*3>G=/94:6XM+:B=Q8*V[9@,W;8_<8QG]164DE.%U/I&`'6-
MJQ*QOI#V"MH80:7AS]KF-]KGLN7.?6'#%/1>I7MNNL8ZA]]&][W5BLOVU/;5
M9^D9D=-]GI;+?]$NUZB\4,KS'':S'?NL/\AP-5G^;O\`4_ZVN?ZM@NR<"_IE
M5PKL<ZS%LLM:;`RO)_2?0=[G[FU;:'V?X:Q)22BGTPVO<7[`UN]QESH&W>_^
M79]-ZNU,,B/DJU#`T-8)(8`P3S#0&>[[E?I;P4E,F-(=KR?#Y(D0=P[Z%*.?
M'B$XX@I*5H1YI)?ZE))2+)J-V-;2/I6,<UOQ(]O_`$D[L_'^RUY=KQ55:&R]
MWT6N</HO?]&O:_V;K/9O4G&!*QLS.R>G,L=B>F/M&YSF6$PQY_P[-N[=[?YZ
MGZ'L_P".24P:#=U'-RR!LLR?LE(.FK/1?ZC/Y7Z+\W_1+>ML=#&R9?8P#7L#
MZMG_`(%6]<UTW%>VO"IQ[(OHI]:YULNK%CV^M7ZM1(]/]&ZO?]G]*SW_`/!K
M2=FN=7^MM^RV9#!50YW\SM?M%SZLF?=Z_L]+[3]GO_FOT/\`.)*=?IY<[#98
M[FW=:/(6.=:T?YKU8(!!!$@Z$%)K6L:&M$-:(`\@G24BNQ<:\`6U-?M!#20"
M6APV.V'\S<W]U-1B8N-575CU,JKJ`;6UC0`T"=&Q_61DDE/_U/54DDDE*222
M24LYK7-+7`.:X00=005SMU#&4NKO<\C`_5;B#+W8[X?A7R[_``K'>C^E_P!/
M58]=&L_J6-9N&90T/L8TUVU.DMLJ=S6X,;8_VN]WL9_V[_,V)3FU%TN%A!LJ
M<&6D:`D@/KN:/W+ZG>I_7]2M7\<\+*?DU"UGV7:XMFLEQBMK1NL?@YF1[JFN
MJC?C65NLO_PNST+K[%<Q<IC]P;+'U';=2_Z=9_E@?3K=_@KZ_P!%<Q)3I`2$
MVV$)EX(Y11:"DI:$QB$Y>$)]B2F%SP&E5*<`9V)EA[&7%SA6QC7FMS0V674.
MM#7OIWUO?N]+^<IO39N0QC1N!>2X!K!RYQ.UE3)_/L?[6_YZL853\;'<QSPV
MQQ-N38-6A[OIOW._<V^E3_Q7J)*<RHW!EO4B678?JFJQLEM+FAWIUW-?'Z3&
MQ_9]']'=B^IO]3[-2MK%J]?(N<^7UM)98]PTM?JQX#?]!C[K*?2_?W_X3WH5
MSK<BRK&:"S<"&-.KFUQMNR;]S?;9Z;O1JJ_X;]-_HZB81MP+V],N`.,01T^X
M?NM&[['=/^%HK_F'?]J,:K])^EIMLL2DE?3/LSV'`N=CU!WOQC^DI+9]S:ZG
M'=C?\']GLJI9_H;5C55?7,48-;"VH48K:;_5<RU[\EFP.R+KCN=9BW5-M^AL
MROM/Z2VKTUTZ22G$QJ?K)5U*@77&_";N%KG>DV6Q:6OL]*JM[K_4-#?3IIKJ
M]+_"_P`YZ^VDDDI__]7U5))))3B_6#*ZU0]G[+K<]K<?(N?M8'S96<=N-6=P
M=O:YMN0_[/5LR;_2_0/59_7>M/M>VO!+*F6FH$,L=8\;MK'M;Z>RK=6W[7^E
M_P"TUM?^'71I)*<"KK_5CD8M-W37,]>QOJ%OJ$,JL;4]C][J6-]2AUVS*9_P
M2O\`V+-RS.?=Z=6L8N,YS6D?\-E?H[[?^M?9JO\`2>LM!))3C9G1ZZ61BU-^
MS;?3..UOM:T3#6UU;7^FUSWOK]#]8QK?YGU=_H*A914;*KJG''N:!359O`/I
M@_T>C*>PT9E37_\`:'/:RZO])_,KJ%5R<%MI-E1%=COI@B66#]VZO\[^O_.)
M*<-U^;CN(MKW`2=Q`I<0)]VU[G8MGT?\#E?\)Z&Q2;U:M@'JA]7F]C@/^W&A
MU?\`TU;MZ?8QNUC7XQY#L>'US_X5L#F?^RO_`%Q5WTWX[3M=C\R7V5&ETG^7
M0[&^FDIC^V<0Z"T./8-EQ^Y@<G;F7W^W&QK;''\Y[34P?-X]5W_6ZE7L'4VL
M<?T./61K=:+B/'V4W7N==_;J]+_!J/3*>HTW"^S/N#`1N.2UE3"(V[*<'%;5
M5_G-]?\`X1)3<IZ=DUY(R<]['VM+OLM-33`)$&S8\^I;D;7;/^X]#%;>12&A
M[?4L<X&G%8=SG/;&U]CM&N]/Z7_<;'_[;4JZ\AX+<=KFN=H_*OD.(_DU_P`Y
M_*V?J]"MXN%3B@ELOM=].Y^KW?%W_?&?HTE,</#=2777.WY-L;W#Z+0/\%5_
MP;?_``1/GX8S,?TP[T[6$6471)KL;K79MTW?\(S_``M6^K\]64DE-+%ZI392
MW[26X^2+!CVTN.K;C_@V3MWMM_G,=_\`AJ?TBLUWTV1L>'$S`!Y#3M<6_P`G
M<J75NBT=2I?7(HLM@67-8TN<UK;6,K>3])C/M%CF*KB_5FO%ZI5GTVAC:C8?
M3;7M);8;W,Q][7^E]GH^T_H_U?U_T?\`2/0WT)*=M))))3__UO54DDDE*222
M24I))))2DDDDE+'A5K#+IG4?@K%GT4$\#Z']KA)32LIMN>/1:'NGZ9^BT=W;
MOSOZM:M8W3Z:'^JXFV[L]W:>?3;]%G_5JVDDI22222E))))*4DDDDI22222G
M_]G_[1JJ4&AO=&]S:&]P(#,N,``X0DE-!"4``````!``````````````````
M````.$))30/M```````0`$@````!``$`2`````$``3A"24T$)@``````#@``
M```````````_@```.$))300-```````$````>#A"24T$&0``````!````!XX
M0DE-`_,```````D```````````$`.$))300*```````!```X0DE-)Q``````
M``H``0`````````".$))30/T```````2`#4````!`"T````&```````!.$))
M30/W```````<``#_____________________________`^@``#A"24T$````
M`````@`!.$))300"```````$`````#A"24T$"```````$`````$```)````"
M0``````X0DE-!!X```````0`````.$))300:``````-)````!@``````````
M````S0```0T````*`%4`;@!T`&D`=`!L`&4`9``M`#$````!````````````
M``````````````$``````````````0T```#-``````````````````````$`
M````````````````````````$`````$```````!N=6QL`````@````9B;W5N
M9'-/8FIC`````0```````%)C=#$````$`````%1O<"!L;VYG``````````!,
M969T;&]N9P``````````0G1O;6QO;F<```#-`````%)G:'1L;VYG```!#0``
M``9S;&EC97-6;$QS`````4]B:F,````!```````%<VQI8V4````2````!W-L
M:6-E241L;VYG``````````=G<F]U<$E$;&]N9P`````````&;W)I9VEN96YU
M;0````Q%4VQI8V5/<FEG:6X````-875T;T=E;F5R871E9`````!4>7!E96YU
M;0````I%4VQI8V54>7!E`````$EM9R`````&8F]U;F1S3V)J8P````$`````
M``!28W0Q````!`````!4;W`@;&]N9P``````````3&5F=&QO;F<`````````
M`$)T;VUL;VYG````S0````!29VAT;&]N9P```0T````#=7)L5$585`````$`
M``````!N=6QL5$585`````$```````!-<V=E5$585`````$```````9A;'14
M86=415A4`````0``````#F-E;&Q497AT27-(5$U,8F]O;`$````(8V5L;%1E
M>'1415A4`````0``````"6AO<GI!;&EG;F5N=6T````/15-L:6-E2&]R>D%L
M:6=N````!V1E9F%U;'0````)=F5R=$%L:6=N96YU;0````]%4VQI8V5697)T
M06QI9VX````'9&5F875L=`````MB9T-O;&]R5'EP965N=6T````115-L:6-E
M0D=#;VQO<E1Y<&4`````3F]N90````ET;W!/=71S971L;VYG``````````IL
M969T3W5T<V5T;&]N9P`````````,8F]T=&]M3W5T<V5T;&]N9P`````````+
M<FEG:'1/=71S971L;VYG```````X0DE-!"@```````P````!/_`````````X
M0DE-!!$```````$!`#A"24T$%```````!`````(X0DE-!`P`````%5(````!
M````H````'H```'@``#DP```%38`&``!_]C_X``02D9)1@`!`@$`2`!(``#_
M[0`,061O8F5?0TT``__N``Y!9&]B90!D@`````'_VP"$``P("`@)"`P)"0P1
M"PH+$14/#`P/%1@3$Q43$Q@1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P!#0L+#0X-$`X.$!0.#@X4%`X.#@X4$0P,#`P,$1$,#`P,#`P1
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#/_``!$(`'H`H`,!(@`"$0$#
M$0'_W0`$``K_Q`$_```!!0$!`0$!`0`````````#``$"!`4&!P@)"@L!``$%
M`0$!`0$!``````````$``@,$!08'"`D*"Q```00!`P($`@4'!@@%`PPS`0`"
M$0,$(1(Q!4%181,B<8$R!A21H;%"(R054L%B,S1R@M%#!R624_#A\6-S-1:B
MLH,F1)-49$7"HW0V%])5XF7RLX3#TW7C\T8GE*2%M)7$U.3TI;7%U>7U5F9V
MAI:FML;6YO8W1U=G=X>7I[?'U^?W$0`"`@$"!`0#!`4&!P<&!34!``(1`R$Q
M$@1!46%Q(A,%,H&1%*&Q0B/!4M'P,R1BX7*"DD-3%6-S-/$E!A:BLH,')C7"
MTD235*,79$55-G1EXO*SA,/3=>/S1I2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&
MUN;V)S='5V=WAY>GM\?_V@`,`P$``A$#$0`_`/4V,96QK&-#&,`:UK1``&@:
MT!22224I1L<65N>UI>YH)#&Q+B!]%N[:WW*222G)I^LO3KK*&@/:W);6:GEN
MFZVO[5Z3FME[/2QW56WVO;Z%7K4_I/TB(WZQ]$<V69;'G:QX8P.<\ML&]FRE
MC76V?HW-L=L9^CJ_26?HU,=#Z6W;MHVEMEMH+7.:=][O5R7;FNW?I7_F_P"C
M_1?S2@_ZO]+)<^NHU6F"VQC[&N:YK!0+*W5V,<Q_HM;5:YG\]7_.I*2GK72@
M:1]JK<<AP93M=NWN)>SV;-V[W56>Y+)ZUTO%M?3D9#:[*VASFF>Y:`S0>ZW]
M+5^@;^F_2U?H_P!(L_I_1.D9.*YEN,UEE;A3DT,?8VIKZ27133ZFVNA[[/M5
M;/S_`%O6L_2JS?\`5_"R,]^9>7O#P"*`=K!:WTMN6WT]K_M36X]-;+M^]E?L
M24VL#J.-U!MMF*[U*JWAC;006OW5UWA];FD[F;;]O]=6D##P<7"K=7C,]-KB
M'.$DR0UM6XN>7.^A6Q-EMR=A?C$>J.&G4'R<TEO_`%=:2FPDN>_YP9#+1CV,
M;1F<C&>20\?F^DYS66-<_P#U]17.E_6+!ZC:<831EMF:+.3MT?Z3O\)L</?_
M`(1GY]:2G522224I))))2DDDDE*22224_P#_T/54E0ZUF9&'A>MC[6DV5L?=
M8"YE3'N#+<FUC',<ZNEO\O8S^<N?71ZMBQV?6O+])U?V=EV0UKW!["YK2QHM
MLIS[J-EUF+TW)IH]EWJ7V>O;73Z=M?ZPDIZ=)8N/]87V5YCG8YG#H-WI@D6O
MVM]3^8V%M=5\[<6SU_T_Z7]'^B0+/K3DTVV46=-L]6JNQ[@Q\M+F&UGZ%SJZ
MWVT_H=K[_3_167T_HDE/0I+GLGZU7XSQ6_IMS[&V&BQK':>HW875X[[65?:-
M]-].1C_S7K4_:/YNW%LJ6Y?D4X]?J7.VMD`0"XDGZ+&,9N>][OW&)*:EI&#U
M(7D[<;.`9:3H&WL'Z*UQ_-]>AOH/>[\^C$K_`,(FR.KL;M%(!]0Q78^8>?\`
MNM2S==E?O>S91_W86?U3).56]ESQ0&^[D;<8#W-SLMT^C9?18QKJ,;=LKN_T
MG^#RLK/8W'#LMS@Z]HW-:2,B\`]K?:_#Z98[W[7_`*WDU?H_T5*2G7MZG=:7
MLWO=8P0^IDMV&/:ZYM#G.H_XO(ZC1_86??U2BO3(LJM?I._TR9'\F.H_^?5A
M9G4;LMK:6L;1BUZ5T5Z,`^`^D_\`EJJ&I*=F_/Z3E`-RL?&R&@0-[*I$_N[L
M.K_SZQ6.GOZ"T/J+74UN+=N]SG,#A]$MR3?DVXSV_P""]/-Q_P#BE@!A3BI[
M7;ZR6N'<:)*?1,6QS*@_&R#G8_$%S7/$:'9<S;ZNW\]EOZ7_`(7_``:N56UV
MMW5N#@#!\0?W7-_-?_)<N"Z'U=V!D.-@#&/#?7#1`VM/]+:QO^%H:Y_VEG^'
MQO\`B&+LW.+K!;4`,EHU9/MM9S&[_P`]/_P?_%V)*;J2A58VU@>S@^/((T<U
MW\IKOI(/4,PXE`-;?5R+7"K&JXWV.!+6DZ[:VM:ZVY_^#HKMM24TNK9^9[L?
MI`-V9C%ME[`!MVN:]U=-C[-K=UKMGLJ=ZS*O?^B]2I#P\OKPZC7C95`=CN-F
M^YK"-`Z_9;N-CJZZG[,?TJ=UN3^E_P`(S?D5:.!AC#QA3N]2PEUEUL1OL>39
M=9M]VW=8[VL_P;/T:LI*4DDDDI__T?55$-8'$@`.=JXCDQIJI*ODTW.;NQWA
MKQ^:_P"B[YM]]?\`QC$E,[765^YK2]O<#D?!4W]0K>'>@YS_`$X]1M?NL9/#
M_3/\[5_K6@5]5M8XUW,?O88LJ@&Y@G^<]/\`[58W_#T?I?\`@K$'.Z?7DV,Z
MAAW'&O<"&YN,!8PCG;DXY]ME3O\`24O9;_+K24Z%/5:#4UUYV.(D.:'.8\?O
M4.;NW?\`%?SS%3O?DWY+7@/KM)FMH`WUT:_0;9^B^VYMC'-_2?S&+]/TO3M]
M2IT.W,^T]1LR;6UXU+F;G,AM#K/<^V^FW^IZ?KU[/YS_`$MGZ5X^LY#&8[FD
MO#LYH=<V8<*&-#'N;J'UNRG>GB[W^_T_524T>I]08(=60ZJL@8K1[FOM82VS
M-]_\[1C_`,SA>I_.7^MF?I?T=JQ'.?;8]]I+WV$OW.U)</I:_P`NO_STC6.?
M=8;'Z&`&M'#6CVLK;_)8U.RF>"0>0X<@C5KO[*2D#:YX'S1ZZ"58QVLL<1+3
M8W^<#>`9<W@?0W[/49_(5VO&',)*:+,;R1!C>2TFXX4_LP^*2G&MQG!S'L'O
M:X;/B2NCZ([;TUK\JUE5=%@;0YSA+:G%K,3?K[=SCZ5>_P#G:O35.W&&PQH>
MQ\U6.7D]-IOJQ#Z+LM_J"UH;N;:&PW^<]CF/L91ZE>S^8^T?G^FDIZ/&S\=[
M'9U9%=9>^O,87-(;97[7V;VN]-WI-K_2[/\``_\`$I^GU6Y.0_JF3(#P6X-+
MA!KI.V7N_P"&RW,;<_?[Z:_3H_TJYHUC[1;=@-;^G95=E42179N#+FXN16W_
M``GYEG_=7T?YYF196N@KZDVFBAV+6_(;F#]5QF_38X?SM=MA_1UT8[OYWW?H
M/YJJNWV5I*==4L;K'3<IKGU7C8"P![PZMKO5.W'?2ZYM;;ZLAW]'NI]2J_\`
MP2C7AYMSVV9V1#00X8N/+:Y':VX_I\G_`-EZ;?\`"XRJN^K&*_&9BORLE]-4
M-H:7,BNH,LQOLS!Z6W8['OMI=?9ZF=_W;24Z7V_!]3TOM%7J#<2S>W=%9VW>
MV?\`!._G/W%*O*QK'AE=S'O+18&M<"2QWT;(!_FW?OK,N^JO2;J32YKVL.WZ
M)`/M;?6SW;?^[ESOY?\`A/\`">HV+]5NG8N?C9['VFW#:]E+26A@]5K67G8R
MMG\YZ?J[6?H_5_,24__2]525/J_4/V9TZ_.])V1Z`!]&N-[I(9L9N_/]RS_^
M=W3&OL]7<REEOIMR!#V.9MI<S*_1D[<>RW(]*I__`%W^;24ZV1B8V4T-R*VV
M!NK=PU:?WF.^DQW\IBRLKHN9476]-R'-L=JX.=M<?C9M?7=_Z%4VV?\`#H[N
MOX@H-GIVMM:=IHL:6/#MHMVOW>QOZ%WJ_21<+K?3<UCW56AFRQU1;9#"7-:R
MWV;OYQKJ;JK?9_I$E.=AYXNZ?9=U00[&N%&33M$/>TM>QWI#?^;9ZEE;/S_Y
M"Q.K8K:LFVNM@K:;`]X:(#K'54V6.='\NQW^>NCRZV59%EE39WWTW/T#FESV
M.P]_;;]"O=M6!URHCJ]%P+AZE[,:QLF'-MQVNIFOZ'J-R:V;+?YS_!I*:5=!
M)U5NG''R1:L>=>/AXJ]5C@P"DIJXO3::[[,AC`U]P:+2W0.VSLL</])M=MWJ
M_7C?<C55!NFWX^'BK#0WM]P24UVXX"EZ*LM:#QHGV!)35-+2#N,-@[G>`[E/
MC=/QK:-^54RW[2T;FO:"&5.^C0S=]']]_P"?ZG]1BGF#;B7$:>PB?ZWL_P"_
M*X\`>T:`"`/@DIP,,"AE-'YN#?9AODDDU$M-#W?U?48S^VM$8_H6$U>UN0X!
MP/T6W#W8]T?RG,]*W_2?HEB=0M;C=;S&N>!5?[MA)@/:,:UENUO];])_Q="W
M+>HX3FG](='L<)KL_->U_P#H_))3IU6"RME@$!X#H/:0IK/HZIA-KVE[M'.`
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MU8K+]M3VU6?I&9'3?9Z6RW_1+M>HO%#*\QQVLQW[K#_(<#59_F[_`%/^MKG^
MK8+LG`OZ95<*['.LQ;++6FP,KR?TGT'>Y^YM6VA]G^&L24DHI],-KW%^P-;O
M<9<Z!MWO_EV?3>KM3#(CY*M0P-#6"2&`,$\PT!GN^Y7Z6\%)3)C2':\GP^2)
M$'<.^A2CGQXA..(*2E:$>:27^I224BR:C=C6TCZ5C'-;\2/;_P!).[/Q_LM>
M7:\556ALO=]%KG#Z+W_1KVO]FZSV;U)Q@2L;,SLGIS+'8GIC[1N<YEA,,>?\
M.S;NW>W^>I^A[/\`CDE,&@W=1S<L@;+,G[)2#IJST7^HS^5^B_-_T2WK;'0Q
MLF7V,`U[`^K9_P"!5O7-=-Q7MKPJ<>R+Z*?6N=;+JQ8]OK5^K42/3_1NKW_9
M_2L]_P#P:TG9KG5_K;?LMF0P54.=_,[7[1<^K)GW>O[/2^T_9[_YK]#_`#B2
MG7Z>7.PV6.YMW6CR%CG6M'^:]6"`001(.A!2:UK&AK1#6B`/()TE(KL7&O`%
MM37[00TD`EH<-CMA_,W-_=348F+C55U8]3*JZ@&UM8T`-`G1L?UD9))3_]3U
M5))))2DDDDE+.:US2UP#FN$$'4$%<[=0QE+J[W/(P/U6X@R]V.^'X5\N_P`*
MQWH_I?\`3U6/71K/ZEC6;AF4-#[&--=M3I+;*G<UN#&V/]KO=[&?]N_S-B4Y
MM1=+A80;*G!EI&@)(#Z[FC]R^IWJ?U_4K5_'/"RGY-0M9]EVN+9K)<8K:T;K
M'X.9D>ZIKJHWXUE;K+_\+L]"Z^Q7,7*8_<&RQ]1VW4O^G6?Y8'TZW?X*^O\`
M17,24Z0$A-MA"9>".446@I*6A,8A.7A"?8DIA<\!I52G`&=B98>QEQ<X5L8U
MYK<T-EEU#K0U[Z=];W[O2_G*;TV;D,8T;@7DN`:P<N<3M94R?S['^UO^>K&%
M4_&QW,<\-L<3;DV#5H>[Z;]SOW-OI4_\5ZB2G,J-P9;U(EEV'ZIJL;);2YH=
MZ==S7Q^DQL?V?1_1W8OJ;_4^S4K:Q:O7R+G/E];266/<-+7ZL>`W_08^ZRGT
MOW]_^$]Z%<ZW(LJQF@LW`AC3JYM<;;LF_<WVV>F[T:JO^&_3?Z.HF$;<"]O3
M+@#C$$=/N'[K1N^QW3_A:*_YAW_:C&J_2?I:;;+$I)7TS[,]AP+G8]0=[\8_
MI*2V?<VNIQW8W_!_9[*J6?Z&U8U57US%&#6PMJ%&*VF_U7,M>_)9L#LBZX[G
M68MU3;?H;,K[3^DMJ]-=.DDIQ,:GZR5=2H%UQOPF[A:YWI-EL6EK[/2JK>Z_
MU#0WTZ::ZO2_PO\`.>OMI))*?__5]522224XOU@RNM4/9^RZW/:W'R+G[6!\
MV5G';C5G<';VN;;D/^SU;,F_TOT#U6?UWK3[7MKP2RIEIJ!#+'6/&[:Q[6^G
MLJW5M^U_I?\`M-;7_AUT:22G`JZ_U8Y&+3=TUS/7L;ZA;ZA#*K&U/8_>ZEC?
M4H==LRF?\$K_`-BS<LSGW>G5K&+C.<UI'_#97Z.^W_K7V:K_`$GK+0224XV9
MT>NED8M3?LVWTSCM;[6M$PUM=6U_IM<][Z_0_6,:W^9]7?Z"H645&RJZIQQ[
MF@4U6;P#Z8/]'HRGL-&94U__`&ASVLNK_2?S*ZA5<G!;:394178[Z8(EE@_=
MNK_._K_SB2G#=?FX[B+:]P$G<0*7$"?=M>YV+9]'_`Y7_">AL4F]6K8!ZH?5
MYO8X#_MQH=7_`--6[>GV,;M8U^,>0['A]<_^%;`YG_LK_P!<5=]-^.T[78_,
ME]E1I=)_ET.QOII*8_MG$.@M#CV#9<?N8')VYE]_MQL:VQQ_.>TU,'S>/5=_
MUNI5[!U-K'']#CUD:W6BXCQ]E-U[G7?VZO2_P:CTRGJ--POLS[@P$;CDM94P
MB-NRG!Q6U5?YS?7_`.$24W*>G9->2,G/>Q]K2[[+34TP"1!LV//J6Y&UVS_N
M/0Q6WD4AH>WU+'.!IQ6'<YSVQM?8[1KO3^E_W&Q_^VU*NO(>"W':YKG:/RKY
M#B/Y-?\`.?RMGZO0K>+A4XH);+[7?3N?J]WQ=_WQGZ-)3'#PW4EUUSM^3;&]
MP^BT#_!5?\&W_P`$3Y^&,S'],.].UA%E%T2:[&ZUV;=-W_",_P`+5OJ_/5E)
M)32Q>J4V4M^TEN/DBP8]M+CJVX_X-D[=[;?YS'?_`(:G](K-=]-D;'AQ,P`>
M0T[7%O\`)W*EU;HM'4J7UR*++8%ES6-+G-:VUC*WD_28S[18YBJXOU9KQ>J5
M9]-H8VHV'TVU[26V&]S,?>U_I?9Z/M/Z/]7]?]'_`$CT-]"2G;22224__];U
M5))))2DDDDE*22224I))))2QX5:PRZ9U'X*Q9]%!/`^A_:X24TK*;;GCT6A[
MI^F?HM'=V[\[^K6K6-T^FA_JN)MN[/=VGGTV_19_U:MI)*4DDDDI22222E))
M))*4DDDDI__9.$))300A``````!3`````0$````/`$$`9`!O`&(`90`@`%``
M:`!O`'0`;P!S`&@`;P!P````$@!!`&0`;P!B`&4`(`!0`&@`;P!T`&\`<P!H
M`&\`<``@`$,`4P````$`.$))300&```````'``0````!`0#_X1@#:'1T<#HO
M+VYS+F%D;V)E+F-O;2]X87`O,2XP+P`\/WAP86-K970@8F5G:6X])^^[OR<@
M:60])U<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"<_/@H\>#IX;7!M971A('AM
M;&YS.G@])V%D;V)E.FYS.FUE=&$O)R!X.GAM<'1K/2=835`@=&]O;&MI="`S
M+C`M,C@L(&9R86UE=V]R:R`Q+C8G/@H\<F1F.E)$1B!X;6QN<SIR9&8])VAT
M='`Z+R]W=W<N=S,N;W)G+S$Y.3DO,#(O,C(M<F1F+7-Y;G1A>"UN<R,G('AM
M;&YS.FE8/2=H='1P.B\O;G,N861O8F4N8V]M+VE8+S$N,"\G/@H*(#QR9&8Z
M1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2=U=6ED.C5F868S83<T+6,R9#,M,3%D
M82UA-S5C+3@T.60X,35A8S-C8R<*("!X;6QN<SIE>&EF/2=H='1P.B\O;G,N
M861O8F4N8V]M+V5X:68O,2XP+R<^"B`@/&5X:68Z0V]L;W)3<&%C93XT,CDT
M.38W,CDU/"]E>&EF.D-O;&]R4W!A8V4^"B`@/&5X:68Z4&EX96Q81&EM96YS
M:6]N/C(V.3PO97AI9CI0:7AE;%A$:6UE;G-I;VX^"B`@/&5X:68Z4&EX96Q9
M1&EM96YS:6]N/C(P-3PO97AI9CI0:7AE;%E$:6UE;G-I;VX^"B`\+W)D9CI$
M97-C<FEP=&EO;CX*"B`\<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TG=75I
M9#HU9F%F,V$W-"UC,F0S+3$Q9&$M83<U8RTX-#ED.#$U86,S8V,G"B`@>&UL
M;G,Z<&1F/2=H='1P.B\O;G,N861O8F4N8V]M+W!D9B\Q+C,O)SX*(#PO<F1F
M.D1E<V-R:7!T:6]N/@H*(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2=U
M=6ED.C5F868S83<T+6,R9#,M,3%D82UA-S5C+3@T.60X,35A8S-C8R<*("!X
M;6QN<SIP:&]T;W-H;W`])VAT='`Z+R]N<RYA9&]B92YC;VTO<&AO=&]S:&]P
M+S$N,"\G/@H@(#QP:&]T;W-H;W`Z2&ES=&]R>3X\+W!H;W1O<VAO<#I(:7-T
M;W)Y/@H@/"]R9&8Z1&5S8W)I<'1I;VX^"@H@/')D9CI$97-C<FEP=&EO;B!R
M9&8Z86)O=70])W5U:60Z-69A9C-A-S0M8S)D,RTQ,61A+6$W-6,M.#0Y9#@Q
M-6%C,V-C)PH@('AM;&YS.G1I9F8])VAT='`Z+R]N<RYA9&]B92YC;VTO=&EF
M9B\Q+C`O)SX*("`\=&EF9CI/<FEE;G1A=&EO;CXQ/"]T:69F.D]R:65N=&%T
M:6]N/@H@(#QT:69F.EA297-O;'5T:6]N/C<R+S$\+W1I9F8Z6%)E<V]L=71I
M;VX^"B`@/'1I9F8Z65)E<V]L=71I;VX^-S(O,3PO=&EF9CI94F5S;VQU=&EO
M;CX*("`\=&EF9CI297-O;'5T:6]N56YI=#XR/"]T:69F.E)E<V]L=71I;VY5
M;FET/@H@/"]R9&8Z1&5S8W)I<'1I;VX^"@H@/')D9CI$97-C<FEP=&EO;B!R
M9&8Z86)O=70])W5U:60Z-69A9C-A-S0M8S)D,RTQ,61A+6$W-6,M.#0Y9#@Q
M-6%C,V-C)PH@('AM;&YS.GAA<#TG:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O
M,2XP+R<^"B`@/'AA<#I#<F5A=&5$871E/C(P,#8M,#0M,#-4,#$Z,S,Z-3$M
M,#4Z,#`\+WAA<#I#<F5A=&5$871E/@H@(#QX87`Z36]D:69Y1&%T93XR,#`V
M+3`T+3`S5#`Q.C,S.C4Q+3`U.C`P/"]X87`Z36]D:69Y1&%T93X*("`\>&%P
M.DUE=&%D871A1&%T93XR,#`V+3`T+3`S5#`Q.C,S.C4Q+3`U.C`P/"]X87`Z
M365T861A=&%$871E/@H@(#QX87`Z0W)E871O<E1O;VP^061O8F4@4&AO=&]S
M:&]P($-3(%=I;F1O=W,\+WAA<#I#<F5A=&]R5&]O;#X*(#PO<F1F.D1E<V-R
M:7!T:6]N/@H*(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2=U=6ED.C5F
M868S83<T+6,R9#,M,3%D82UA-S5C+3@T.60X,35A8S-C8R<*("!X;6QN<SIX
M87!-33TG:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O,2XP+VUM+R<^"B`@/'AA
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M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*
M/#]X<&%C:V5T(&5N9#TG=R<_/O_N``Y!9&]B90!D``````#_VP!#``8$!`0%
M!`8%!08)!@4&"0L(!@8("PP*"@L*"@P0#`P,#`P,$`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`S_P``+"`#-`0T!`1$`_]T`!``B_\0`T@````<!`0$!
M`0``````````!`4#`@8!``<("0H+$``"`0,#`@0"!@<#!`(&`G,!`@,1!``%
M(1(Q05$&$V$B<8$4,I&A!Q6Q0B/!4M'A,Q9B\"1R@O$E0S13DJ*R8W/"-40G
MDZ.S-A=49'3#TN(()H,)"A@9A)1%1J2T5M-5*!KRX_/$U.3T976%E:6UQ=7E
M]69VAI:FML;6YO8W1U=G=X>7I[?'U^?W.$A8:'B(F*BXR-CH^"DY25EI>8F9
MJ;G)V>GY*CI*6FIZBIJJNLK:ZOK_V@`(`0$``#\`]4YLV;-FS5%:5WZTR@RD
MD`@D=0,O-FS9LQ('4]>F;-FS9LV;-FS9LV;-FS9LV;-G_]#U3FS9LV;(3YZO
MHO+6M:9YQG:FG00W&FZJ*5(BG`EMV7_*^LPI!_E?6,A*2ZYI.KZ59M+!8ZA<
M7>C76MS2IZG.349=1FE@`+(D:QR#TXV7XVPWOOS%\Y1/PBCM'6]U:\TRQEBB
MKZ4>GB0L\GK7-O')+<<!P3U8N"*_][C8_P`SO,UYI5YJ2S:5I3:580WDUE<D
MSF\>2%YF]":.956%O3]*)T%Q\7J?R8+D_-74/2552SAOGO\`4+46=S(8F2*U
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MIO\`LX9V5A86,/HV5M%:PU+>G"BQKR/4\5`%<(]*\AZ+IVKW&J*\]U/.DL02
MY=9$2.X</*J_"'<.54?OGE9418U^##BTT?2+-!':6-O;('$@6*)$',"@:B@?
M%3;E@O$;J#UHRM`WL=ON/;(3K.NZ[HUP$6,7,+=+:<^G(/=)-T<8E#YIEN%$
MED[0W0%9+5Z<A]'1Q\L%6'YH:8DHM]87ZK*6XB==XR/$]QDUBEBEC66)Q)$X
M#(ZD%2#N"",=FS9LV;-FS9LV;-FS_]+U3FS9LV;-FS9LC5D!I'G&\M7-+77Q
M]<L^RBZ@14N(Z#:KQB.8?M-QF_ER2YL2NKNUM(C-=3)!$O621@BCZ33"M_-%
MJR%[.VN+N)06:X6/TH`HZMZLYBC*CQ5FP%-YO:J"/ZA`L@)1[J]1=EH&_NDE
M78G_`'Y@&Z\S1W$12\OM%EA)J(G$LP)4^_6E?Y<Y[K/E6YN;_P"M:)YCTR*1
ME,PMBTZHH7=N#1@\?\E./+`%YY?\\W!2XN])2_A50&O-)G2Z213WFMW,=R9!
M_DI(W^3\/')AY..M:#:*-))U>R509]/=GCFC%:DI&_'@?]:+)_I/F;3-2984
M+V]V5J;6X0QOMU`K\+T_R&;#;-FS9LV!M3U&STS3KK4KZ3T;*RB>XN9:$\8X
MU+.U%!)HH[9I-1M46V8EF6[94@*([[NI8%N(/!:#[;\5P0KHU>+!N)HU#6AR
M\V;-G__3]4YLV;-FS9LV;"CS3I,VHZ4?JE!J5FZW>FN=J7$/Q("?Y9-XI/\`
MBN1L2M/.&CW&EVEZ'/KW:`QZ>HYW/J;AH_3'Q<D='1_V5X-\6%VK:]<1J1J-
MV-,Y@&+3;4QO>N&-!SE>L4=3_)]G_?\`A)=7B:?(MU-;0Z7&S#A=W;M=7,O4
M_NC,LDE:\&I'&W^O@2YO)[Z%B\%Q/:24,DFIW#P0.0:\A;HQD_V/J1K_`)&%
MTVM:?85X7%C:24"L+2U65Z**`>K/ZK;`4PNG\\M7X=4OB.W#@@^Y5&!_\;7!
M.VJW>_:9(IE^D.AR_P#%1D!!2PN2Y!9PDEE,2IJ/C@9%Y5_:X9+M-_,#3KCT
M8=31K:9*")KEAU'0Q7:<5K_QD]'E_,V32VU'0-<@X<HKE%-&965BC@E?M*>4
M;U4\3\/^3B_KW6F_#=%KBQ'V;NE9(QX2@?:7_BU?^>G\^&$,T,T8DAD62-NC
MH0RFFW48_-FS9"O-.HW?F;3_`#'Y7T2V]9OT?>6MQ>RGTX1<2PF.&*-J$.?4
M+K*?]U>DV%/_`"KS51?RWZ01"]FUF*YDN!*5<V$>FBW$?-?B51<5/IK_`,9?
MM8[\LO*.O:%JK-<V`M+%;%;=WG-HUPTJ.O`))9+&)H@H?E+=Q_66;C_-(N=)
MS9LV?__4]4Y%;+\R=`O+RWBCANTL+R<VECK$D!6QGG!*A(Y:U^-E98G9%BE;
M^[=_APZF\P:)#9WMXU]"UOIT;2WSHZOZ2*I<EPI)7X17$[?S+HTUJ]X;E(;)
M3&$NYG2.*031K(A1RU#4.!_K8/GNK6WA,T\R10CK([!5W]R:8BVL:0L-O,U]
M;K#=D+:RF5`LK'H(VK1R?\G'/J>FI<I:O=PK=25].`R*)&H:&BUY'*EU73(G
MC26\@C>:0PQ*TB*7D78HH)^)Q_*/BP4""*CIFPGU759Y'FTS23RU$+^^N-O2
MM`PV>4D,.?[20TY/^UP3X\Y]#?7VDZ_/I^DEI+;4G+Q:DR\?5OB@,T'-P\@:
M9H9)OM\/CQ6[N1%-<V6CHD^O&@GOE(-O8MU>C,&1Y2WQ<8T^!OV\*I+_`$/0
MU>>6;])ZNXWNG+.P;]K>0O2K5;;(;JNNW^H2LTLSN"=@3L!A<.1J2:G+XY?'
M*:($=-\?!=W5M5:EX3UC-"/Q!P]\NZVMCJ$&H:?$8[B`@WELE!]8MZTDCZ<3
MMN*KG=='UNQO+:.:WG$]K.`UO,#4`']ANZLO0AL=<6KV-P+VR3_1Z$7=I$*<
MQM21%Z<TI]E>+.O^Q7#&&:*>))HF#Q2`,CCH0<?FPC\VZI<6NGK8:>Q&LZJ6
MM=,"TJLC*>4YV/[NW7]ZYI_D_:=<,-'TJUTK3+;3[90L5N@0$5^(]6<U+'D[
M$NQ+?:;!F;-FS9L__]7U-/`D\3125X-2M#0[&O49SZS\E>;?T5I/E2\:R_P]
MH]Q;2IJ<3R?6IX+"59K:(P%`D4O*.-9Y?6=>/+TT^/X(_H'Y9Z]JFEZ5<7=O
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M;R_NH?WO\G3/+VF-I6@Z=ICOS:RMHK=GJS`F-`I(9R7/3]KXL!3WU]JDDL>F
MW`L].@Y+<:F5#%V!HZ0<OA_=_%RG;DBR?#Q?X\)II)YK<:;IL(L])EA=IYIN
M)+QO0M<2.Q)XNO*KM\?+^;]B+:CJ$-[9&STY$MO+T+J[ZS*/])F>%@U8J[HC
M,%X'[7P_Y61;6_,_*W2QT>/ZII96J!=G?<AN1\0P(R.&K=23\\>J#'".IQ18
M3UIBBP5&/%J?#+:SJ-Q@9[:XMY%GA)5XZD4[Y./(/F&.UOEA<*MAJ[!9!L!%
M>4HC?ZLW]VW^PSIT&H26<BK(&^KL:,K?:0_Y[XO-+%I,S7-::9<$M,1NL4IW
M#@#]B7]K_BS_`%VPV!!`(-0=P1B5Y=VUG:37=U(L-M;HTDTKFBJBBK$_(81>
M6K2ZO+F7S)J*&.YO4]/3[9A0VUE7DBD=I9]I9_\`81?[JR19LV;-FS9__];U
M3FS8G.C,E4^T,!1ZFB.T=Q4%=MQOC;B]2)3)#^^@']_"!4T/@II\7M^U@*'6
M;6(_6K2?ZSI2U%TJUD>`]0>/VU51]M?V?Y?M8?12Q31++$ZR1.`R.I#*0>X(
MPGUF>:]NX]%LW(Y%7U25"5]*V-?@YC[$LQ^%:?%Z?J-\'POA'*UO>:F_)'BT
M.Q5;/3[6-2BW$HW=!'NLD1`6.OP+A%YJOS<W(T..4"W@`F\RR(:*7`!CM@X_
M80?[J`_E_P`O(!KVLR7DSQQL1:K18H@**%7IMA5`I9982*_[OB'N-I0/]CP?
M_8LV.">V*+%RZ#Z1B\5N3U6M,%):^V"4M>GPXJ+4_P`N.%K[8G/9\XV6G7`4
M</!+M#\,7IDM_DLNZGV(SL?E?](:AY>LKV_#&YE]19UD!#'C*X0T_P!7#BWU
M.Q@OHM&G++/-&9;42*>#HO5`Y'$R)3EP^UP^+'V+&QNVTZ0D0/\`%IY._P`(
M%6BY>*'["_[Z_P!5N)#=P77F?S/Z*R%O+.D2".]A)XI<W:DR%"*-ZJ6[K!7[
M"\_53]Y\2Y,<V;-FS9LV?__7]4Y35I\/7`+:DB2&.H61?M1/M^/;%K?4+>=F
M1#^]2ADA.SJ#T/'NO^4/AQ.[AM+R,QNU&_984#*?;^ASG7F$^8?+%\+X(TVD
MU_?,E7C"D[L!UB/\R?W3_P"3BT>NZ3>QIJNC7,272-PIZ@].6HYF,G8\M^01
MOWJ_:7]K#70IO+^K6\L\)N+682K#>VEM/)#25@21(D;(O0<O43[:?\#@W6I+
M'3O+\MK81B*.XF]"<&KR.L@_>R5)9W;BU7D?EQ7"C7]<;0+6WATRW#:G?(R6
M4+"GU>V^R)W`_;>4I(]?M?9_W7G-]8ODAMQIMJY<`E[N<FK2RDU9F/??"41X
M[T9!Q>/^^C(>.O3D.Q]F'PM_DM@E;:!U2:!N<,FX\5.Q*-_EJ"O+!<-E[4/M
M@N&T([5'CWP;%9GN*^&"$L]NGT8H+3'?5#W&4UF?#`+V0421A0Y)$G!M@U&Y
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M9B&1U/=7)XT(_P!;(%YJ\L^65MI]0LH8M$U4H?70*$AG`)?C/"_".9>9:C#B
MZ?L28/\`RKTLVWEEM4NK7ZC<WDSRLC$L`@^!6JY9N"Q+50S?"O+#^VECOII3
MP'U))I/6O&6B"**G,*[`#C,XH_%O[M?]GG,/,.O2WFI7VKJU3=R-#:'>@MH@
M50K6FS']Y_LLC(2IJV['KBBQ=-L$Q0;],P%O922,](K>9'D=CL!-&"X/SD7F
M/]BN'%I$LB*U*!@"/I%<,8;4"FV"HK4?9/3MBZ6P`&U<5%NO<?ACA;[]#3WR
MS;"G3`-Q:#U2]-T``^G">]EO+%@UI\!,T-RK;CC)!R`V!')75RCJ<4\OW%HE
MAK<=W)#IT?.&_CEV6.-BYA**"?LTEXK\6:/3;J>)-33G:7P82P+'L;=14Q(O
MR5N3\OMO))S_`)%Z+8ZO:ZKY976;R1+34-/5_K$X_P!T2QT+5'\D@"DK_OM_
MM8A8WGF;S27<&70M#!I'-$!]:NEZ$JTG%[9?^>'J?R2+A_I/ES0])+/I]G'#
M-(*37%.4TF]?WDK5DDW_`)VPQ*JWV@#3<5\<Q532H!H:BO8Y>454TJ`:&HKX
MCOFXK4F@J=B>],O/_]'U3FS8V6*.6-HY462-A1D8`J1X$'(U=^1K16:;29WL
M9MR(JF2`U'V>!-5'^HV1NXCU_P`O.TBJVGJ35WA`FL)#XM&:>D3_`#+Z#?ZV
M)6_GN.2[2VURSA$,K*$N8F)B!+?#S#[IR/1ZR)_/Q_O,EDD5U?VYL&1A!<%5
MG+#B?19^4H_V0Y1Y#?./EBPM'M[B'FMK%<FQEMU=A'(OI"2(NM>)*_$G^KQR
M"7;2RW#%Z"AHJ]``.PS)%7M@F.V-1M@V"UKVQ+6?*MKK%H89"8IP/W,X_9/@
MP_:7#[1]/F2PMTN`/66-%DIN.2J%-/NPTBM`O;;M@I;6HV&++:>`VQ46WMCA
M;[9C;"G3`MW#'$IGE^&&-6+&G4@=,?IWE2VO(OKFLVW*22JQV3GX44;<F`IR
M=NW\JX46.@6?EGSJM#ZNE7L$GI6\])%0CXJ?%4_"5V_UL-+.WCAU:]TPGD(7
M94)%#04=0?\`GG(N+"TN](OOTG9%C&M&O+5>DT:U'3^=%9V3_*XY*+.6&._/
MHMRM-23ZS;D?9Y@#G3_74K)_P>&>;-FS9LV?_]+U3FS9LV4RJRE6`*D4(.X(
M.0+SYY"TE])N+^PA%O+`K//!&/W<L9^V.(^RP'V67_5_U5X]9NG\A:.=Y=1O
M88(XY22%,D=&+.5^+XN'3]O"SS&]Q_AW3?KK(LTE_P"I<,*A`8X&'[78`;UR
M"%$E;FC!D8EE=34$5VH<5AM16HV/AVP=#;L:&B_C@^&W`*D@"N#[:%'J.)![
M5[X:06P`P7%;CPQ=8%`Z8HL(R_1&7Z(ZYC&#@:ZA$U[I]C2J2R\Y0=P5B!D(
M^DJN'\H+'<[Y#/S*C5=,L;WHT,IC+>SJ?^:1C[R]C;6X-0!'*>>"S8"FX$6[
M'?KS>G^QR4(H8"N!+)3#:2P@[Z3>JT!\(9>+<?D(YGC_`-CDES9LV;-FS__3
M]4Y&6_,;RHMCYBO6N66'RM+)!K`,;\D>-`_P+2LG*O&/A]M_APUM?,6AW*V?
M"]A26_BCGM;>214F=)5Y(1&QY[CVP2FHZ>\TL"7,33PLJS1!U+(S_9#*#52W
M[-<1N-;TZWO;2SDE'K7K2K#QW6L"EY.3#9>(4]<$6=]97L/KV=Q%<PU*^K"Z
MR+4=1R4D5&*LH92K"JG8@]"#D+=(M/\`+FC)`XB@LK_T(T?]KTY9(T0R`,4J
M5`)I\7V/VL`>;42ZTVQ$R*\<M].LT?VD/JQ,2N_VEH<YAY:L(;+4]9TB%!%:
MV<\<UI".B1W$88JH[+ZBODGCM:T/2G3WP?;V@$FVVW3MVWPRCM1MMW`^_!L5
MN%VDW4]&\#@^%/%:T_:7<?A@F-%-:=1U&**(_$8HJ`BH((]L=Z8RO3RBF!K-
M0_F/?_=%JQ7YR.!_QKAL_P!H'WR,?F'#ZGE2XVY&*:-@#[MQ_CD(\M7!BLKB
MP(YOIUXJ1,S;^GR2:,TZEA'($Y?Y.=7C\/?$)(*RZJM/[^R1O]DGJ*#_`,1P
M\@D]2".3^=5;[Q7'XE=W"VUK-<."5A1I&`ZD("33[LAVC?F?;W0T^76-,ET2
MTU6S-_IUW<302QO"HC)Y^D[-$U)X_MKQ_9Y<L/;WSEY6L85FN]4MX8W2&1"S
MCXEN>7H%0-V];TW].GV^/PX6ZM^8^AV-H][`1?V@M5O(Y;:2-BZ.91LM>0H8
M&7DW[7P?:5LE>?_4]4YR^Z_*S6Y=1U*5;BW%GJ]Q?3:A`2_[T<VFTZOPTK%-
M(_K?Y''C@&;\JO-,L(A9K3UHI=.D@N8Y%B3A9+;AA(HMFGDE_P!'<+)]95/[
MKX4^-<,8?R^\P6L=NL%EICW.FW(NEU(NZW5^1?+=\97$?[GDBMZA?ZQ^_P"/
M#BF7=?E[YIN-.F(:QCOYY-5F,4A>:`?I!IS&C<D'J!1.JR53C_DLOPX/\H>2
M_,NBQZX\-U!93:G<6\]MS`N^`B@6*19%C2RCJQ3;TE7X<.PGYAQ,/WNDW2]Z
MQW-N?O#SC\,C&I7?F8:#J$,FDPO%97TD\TL5T&XD2BX(5'2(E?WFWQ?ZRX3:
MSYVLX]/M;#4;&YM+HRV]]%)^YD0Q>BJD_!(6'(;\>.0C6_,NG:1JP\TPJ]WH
MU\BZ?><!PDCEB8R))P?CR'I-)7C_`"Y/[:,$`TJ&&Q]B*X96\`"@]S@V"$%U
M'A\1_4,'^EL`.Y4?CB\<*M5Q\);H5VV&6\;AA4AJ="1N0.H-*8(]!"*'<]CX
M?+PR^)7<4]R-J_,8X,#E[8TC"^T<Q^:I%/26SJ/^><@/_&V&[&M#X]\CGGV0
MIY9N@.KRQ*/^"Y?PR"Z1HL]VCWOUFY]&6]]%"D[J41.*5H*5!8'_`"E^'.A)
MY9LR*_7=2_Z3[G_FO$+G0;.'](R?7-1XVMEZQ_TZYZ_O#_/O]CIAI:>4K)K6
M%C>ZD"8U)`O[H#<#PDQ7_"%C_P`MVI?]Q"Z_ZJ9O\)VR))Z5Y?-(\<D:B>[N
M)HZR(4JT;N5:E>^1VV_*'0+/R2^AV$-M::M)80V<NL1P#F[P\&Y,">7IO+&'
M>/GA)>>0/.=E+I%VE[97E];3Z3:0@0,D,<&FK=?O9`\I=VE]?<1G]VWV.6&$
MOY27<MK>+)J<?UC4+>1+EUA(03SW%U<RLB\]HN=YQ1*_9C^U\6=)S__5]4YL
MV;-FS9&[R&3ZSY@L5*CZW!'>1!A4&J&&04_YXK_P>1:33S?(=1M/W>IZ5:^B
MZ*I$4\=JS!D7E\0=$9=_Y_A^SD"_,N&SGO?*KSJ'T^XU&(M$?LEW*<>0[_#Z
MF3N"-AM2G^?AAC!'L!VP=#$:FGVF-*^``P4L%"K%BQ4@[GZ.V+PCX>/<?JQ0
MH"*?<??*0\1[#JO<?V8IL?IR@/PVR^V-.%.I.+;5-/OR:1JYMYSV"3?#4_)P
MF&M_?VEC;-=7DGHV\=.<I#,%!-*MQ!(7^9OLK^UD,_,_4XWT&QBM)E<7TOJQ
M2Q,'#)&O52IH1\6+QZ:NFZA%I<=(H_5@ECA7_?;J68'K_NU&Z_LY,(02!A1J
M#&?2=6E3?])2IIUMX,BGTF8?[)IC_L<ERJ%4*!0`4`S9LV;-FS__UO5.;-FS
M9LV%.J.;;6-,NS_<RM)93?\`/8!XS_R,BX?\],)W26U\XSD1H+.8(9/33A02
M`1L9"?M,S,&Y+_)G(OS.B8V6D:';V\]SK%OJ1-NL,;,J)`S1B21P.*+R>/J<
MZ'&M7)KWPQ@`%*X86Z4(KU)_7@N@`Z5[4S!>("DT/[+8]#6H/4?YURF4!JD;
M'K\\P`&W8],=^O,<8V%VK00W-C-;S?W3BC=MO8X!TK7Q9*;'5[I5N%JT-W*1
M&DJ'<BIV#IT*_P`G'(=;&U\P>?9+30%2SL8T>4W$4221O*HXO*(9!Z7[SGQY
M*$;]OXL,K;5W'F*74-6K(J%EEO[>-W@'#]TKM'\4MNAW_P!^Q_%_>+DPEU$3
MQP6^FR+-/?*?JUS$1)$B]#*66J_"O)D_F9..*R0P2ZQIVF6]?JNF@.PZ_$B@
MBI[LM8Z_\9<DF;-FS9LV?__7]4YLV;-FS87Z_:O<:5-Z2EKB"EQ;`=?5A(D0
M#_69>.1K4+NZO-)LM5@B9Y8A+;:HL;<9%DC^!@1]D\)49AR^)?@X_:PKN(K1
M]::YECB8W\8GMIN*L5D!$<Z(YKTF3EL?Y<?&I5BIV(.&-NJU'<X9PKT/A3!1
M7]>9D#"A[=,:J<7V\*'_`#./-*;],J@(I]QRMQU^_,2,8QPNU!UX`,=B0"/'
MVR(^:$BN%6%H?6;DB)0T?G,2J*E*-R;B>F%_E3U-&.L:E;PHL]@$LHXU(;E*
M\OQ@$5Y`)&^2/0;6VMK.YN+Y0\<B)%+'(H<,!NRE"#S+R-T_:;!D6@7NCV\>
MH6-\=/NI*M%HTD:W,`J:)!&&(FB^W^\]"58U=OL\/M+:)K\%A?3-Y@C_`$?<
M2,T2WK'U+*25G//A<@*J;A(UCF6)OW?'X\FP((!!J#N".E,U16E=_#-FS9LV
M?__0]4YLV;-FS9LBK0PZ=YEO+"84TWS&AD0'[*W:IZ<HWV_?1A&_UU_R\(CH
M:*+O1Y9EMYK:Y];3Y%'!1+,OP`H`52&=AS(1OMQ/]G-:S_68?69#'.C&*ZA/
MVDE0T8'Z<,;=AMAK;,"1@U1E\#3&E:$U[Y1!IFIWRB!7*;88'D<4.$^IW7I1
MM)3D4!.YH!VW.#/*.G/)9:A'J%L8;@S@"1E^,?N5XLCD;\>3<67[#<LAUQ:Q
MVEC8P:-8W-I9L))#/=*.<DRG@'E->`;T]D1N''FWP\L,/+DT>BW45M?P27;.
MI?0;:-Q)Z<BL1);L#Q`E2OJQL_V8.:I_<Y([R9XKE#(4GURZJEFHJ4BK\-$_
MR$#<Y'^U)_P*Y(8-.MHM/6Q=%F@">G(L@#!Z_:+`['F=VPD;R<;`>IY;O9-+
MD2I6S8M/8L.O`V[M^[6O_+.T3+_PN1UO,4&B_F3+-YDECLI;O0[*)3&)I(&F
M2\NN0C?@.S(WQ?%\61O3//'YASZ_/%?3?5+R/4+FW31VC8*U@B.PE2,6S.Q5
MU^&[^M>A^[]-E^/XUI?,/GNTTB$W.M2UO-.TC4;F\N8$@$4MV\RW,"2QV\J6
MJMZ<5))X9O0;[?'U>2SO\M]9O=5\NM->233R0W,T"7,WIL)40CBT<L20I/%O
MP6;T8N?'[&2G-G__T?5.;-FS9LV;"7S9I<M]IGJ6Y(N[-Q<6Y4<CR3>G$_:^
M6$.IH_F#3[?5[.,R7MJK0WUG&0213U"JD_S=8V'Q,DBX!NF%O=MK`(DMKP(F
MJLFX22G".X7OZ4G'@Z_[JE7C@Y5,;#>JG=6'0@X8VT@PPCD&+@@YB`<:5QA%
M,:2!B,DF`YI-CA#J-PK6UT9?A@])P3WIXY)O)^H7+>6K22^'^DR&6B@4)`D8
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M'MX81I;3:Q>&PC_WDB99=5FZ*%ZK`OB\E/\`@?BR7)RD?@H)G?[144XJ.R]A
MBC3/"K6.FND<J&MU=L.:1MU"`;<W_P"(+\3?%A=I]E%?ZFEI&I:PL6]:[=_B
M]65CR4,3]IF;][)_L?YL7\P:9J6FZBWF71BS<5#:QI:"OUQ(AQ#)X3QQ,_'_
M`'[PAC_9R1V5[:WUG#>6L@EMKA%EAD7HR,*@XMFS9LV;-G__T_5.;-F)`!)Z
M#<Y$]/\`S.\MWRV4RQ7T%EJ+QQ66H7%E<16TCS$+"!,R\!ZK$+&6^TS8?7^N
MZ/I]K<75Y>10V]H5%TY8'TRY"J'`J5Y$[9H=;T^3ZP6<P);.8Y))P8D)'=6>
M@9?\H8):[M5FCA:9%FE!,418!F`ZE5K5OHP+JVNZ3I,:/?W"Q&4\8(A5I96_
MEBC4&21O\E%PDN!YK\Q0/'%&-`TV0%1)<<GO9%8%2?2C=%M]C\/.21^7VXUP
MGB\OMY8FBAMD%PI1XF::@^OQONR3N``;E=^#2<D9?]EP3TW1)/TDFHZ%<"58
M4`ET^=O2NPRT!1U^%>`7@OVN++^WQXX6)I]]IFI7-_HT8XW,A-UH-P?JY1SN
M?JM>$7Q?:$3JC_RM)@Z'S'9//Z,Z2V%UU^KW:-$Q\>/("M#MAI%?IX[>-=L$
MQWBD;'%A>*!UQINE/3&F<'$9KA50LQ"J.K,:#(IJ/F"*YN!9:8?KM_(2L5O"
M:DFG4GHJ+^TQR3Z!H8TK38[&%OK-Y*QFNY1LK3,/BHU*^FGV>3<L-(I#Z,EK
MI\BRO)7U[]/[N,$4`0@U>2G0*WP?:;`=],UO%#ING0FYN>/P0J0"0N[.S;*/
M\IC]I_\`6P^T'2OT9IR6[,))F9I;B0"G*1S5O>@^RM?V5PPR+Z-_N`UV?1)C
M2QU266]T>0[*)'/.XM:?94H:S1!?MQM)^U&[-*,V;-FS9L__U/5.;-E."48#
MJ00,YAI/Y4WVEZ+Y5>*5KK5-$EMWO]/N;NXEL)0HXR-%&Y,<<L!/KVK"-55T
MX_M<E*+7\G]?2PU"WGBANK@V<D`EGFC,5[*UW'<JSQI;JPKZ3?O+F2XDBDD^
M#DG-F.;+\L;^37EN]5M[.XTUM6N]1>RD_>J(I[::*-.#+P8H\J_Y/[6%,?Y6
M^<%GT7U%M&;2QHQ6Z1T#!-.D1IT=WA>X=B`ZP^E-##P;]XOVN75;71=-AOGU
M/ZLGZ3G14FNC\<E%4#BK-7BNWV4XJWVL'XE=VEO=V[V]P@DB?JI^\$$;@CL1
MD2U/R_<VK_6&5IXH2#%?PGC=Q#>E>(JP7]HK]K]J+[6!+F<7MLB:S:C5K=:&
M#4;3BETH!KNHHK]/B])OB_WSB4]C:ZHC6^G:I#>QH&8:9?1#U&<[*H63TBBK
M_-%Z;\OV_P!G"B^T1]/=HD>XTV[6C&V0->0LI_;C!I+Q'[?[Q^&!([W5HF*Q
M7=G=E15HW9K60"M/B$P5!T_WY@Y=0\P*H+Z/<&O1HFCD4_(HQRUU'S`W]UI-
MS7_+X(/O9AB,=[Y@N93$DEG;.#Q*-+ZT@;P*PB0<O\DMAU9^1=0NR&U:9[@]
MXY/@B4?\8D)Y?[.3_GGAXN@:-I)>Z98K=I@L;M%&/5EI]E*@5;ILD:?['X<5
M,#31_P"DK]6L:?[R5J\G_&=QV_XJ4_Z[-]G`]UJC/(NGZ7");IA58T`5$4]7
M<@41?^)?LX:Z)HJ:=&\DC^O?3T-S<':M.BJ/V8UK\*_\;89YL+M?T:+5]->U
M9S#.K+-9W2BKPW$9Y12K[HW;]I?@^RV$<?GZ"WT'5[C48N.L^7;22YU;3HS0
MGT49N41;[4<RISC/[*21\\$GS]Y=-_%IT5W$U]ZD4=W;L_`P>K$9AR8C@7X#
MEZ?+GP^/[.#=$\W>7=<E>+2[P7$B1K-QX21EHF-%D3U%7U(S_.G),-\V;-G_
MU?5.;-FS9LV;-FS9L)-5\OM++]:TYDM[@GE/&:A)O];JJM_E\.6%-Y%;O&8M
M7L3"G9IU5XO#:1>2C_9<,"2:5K$`5]%U.2WM^T))N(B/`"1G51_JKF&I>9+5
M?3N;:WU"'?FC<(@Q/4T6%AOA?=:G:/R]7RLC,Q+%EO&!JQJ:$("/HPLO=;AY
MM!:^6XEFF``@^L-*QXTW$8A?P')J?ZV%6I#\Q[MO])UU=%L>OZ/@2(R%=NKQ
M+$RMLN_/GDA\EQZ_9RE+-Y)+-H^,<LSLXY,:O+SD]1I&<_ZW\O+)8GU330;J
M\D#W)'&2ZD/Q.Q[+4GC7^5,1-AJ^M2`_'8V`/Q/)59)%_E1!Q=0?YRR-_+DD
ML--L-/A]&SA6&,GD0O4GQ)-2?IP3FS9L)/-_E_\`3/EO6=/M5BCO]2L+FSBN
M76E#/$4')@"W"O'E_JY''\@:N2:7$`)UQ-5J06'I+IPL^)!6C/Z@Y<3\/#-Y
M$\E:SH>LBY>"#3-.6R-M/86MW-=17%SS0K<+')'%';!$1T6.)?LR<?\`=:Y/
MLV;-G__6]4YLV;-FS9LV;-FS9B`0014'J,+Y-"TLN9$A]"0]6@9HJ_,(0I^D
M8$N].CC_`+JXN&;^3]VZCYLZ[?\`!86G2I)"6NKC]W^S'`!%_P`%)]H_['A@
M2>UCMHVCL(4A#;O+O\1\6<UDD^DX5-I-@K^O>$W$U>1+;*/8+T`^>2'1K+4[
MV,%&-G8THL@4>H_^H&K0?Y;#_5P]L]!TNUF$Z1<[G_?\I,CU\06)X_['!^;-
MFS9LV;-FS9LV?__7]4YLV;-FS9LV;-FS9L9+6FWWGI@.:G[9K3H.V!)!7H/I
M.%ES;W<Y,=C&99CL9#]A?FQH!_Q+#73O+5C"J2W2"XNA1BSGDBG_`"5HH^]<
M.,V;-FS9LV;-FS9LV;/_T/5.;-FS9LV;-FS9LV;$9^5/;VP(W#>M:XP?4*GZ
IP6([<A1/PK_PV&47I>FOI<?3_9XTI3VICLV;-FS9LV;-FS9LV;-G_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>psivida_logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 psivida_logo.jpg
M_]C_X``02D9)1@`!`@$`2`!(``#_X0SW17AI9@``34T`*@````@`!P$2``,`
M```!``$```$:``4````!````8@$;``4````!````:@$H``,````!``(```$Q
M``(````;````<@$R``(````4````C8=I``0````!````I````-````!(````
M`0```$@````!061O8F4@4&AO=&]S:&]P($-3(%=I;F1O=W,`,C`P-CHP-#HP
M,R`P,3HP,3HS-0```````Z`!``,````!``$``*`"``0````!````M*`#``0`
M```!````-0`````````&`0,``P````$`!@```1H`!0````$```$>`1L`!0``
M``$```$F`2@``P````$``@```@$`!`````$```$N`@(`!`````$```O!````
M`````$@````!````2`````'_V/_@`!!*1DE&``$"`0!(`$@``/_M``Q!9&]B
M95]#30`!_^X`#D%D;V)E`&2``````?_;`(0`#`@("`D(#`D)#!$+"@L1%0\,
M#`\5&!,3%1,3&!$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`$-"PL-#@T0#@X0%`X.#A04#@X.#A01#`P,#`P1$0P,#`P,#!$,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,_\``$0@`+P"@`P$B``(1`0,1`?_=``0`
M"O_$`3\```$%`0$!`0$!``````````,``0($!08'"`D*"P$``04!`0$!`0$`
M`````````0`"`P0%!@<("0H+$``!!`$#`@0"!0<&"`4###,!``(1`P0A$C$%
M05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D
M1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F
M]C='5V=WAY>GM\?7Y_<1``("`0($!`,$!08'!P8%-0$``A$#(3$2!$%187$B
M$P4R@9$4H;%"(\%2T?`S)&+A<H*20U,58W,T\24&%J*R@P<F-<+21)-4HQ=D
M154V=&7B\K.$P]-UX_-&E*2%M)7$U.3TI;7%U>7U5F9VAI:FML;6YO8G-T=7
M9W>'EZ>WQ__:``P#`0`"$0,1`#\`]52253/.36P6TVBMK.6.#8)/T=S[',V)
MF7)[<#/A,N'4B-<5?X7"D"S3;25/%S+<S$+ZMK+VG:X.ES9']4CVN:J#^K9[
M,@T$5%X?LF'1,[?WE6R_$<&.&/(>(PR_)*,;L_N_WDB!-CLZ/4.IX'3,<Y.?
M>VBJ=H+N7./%=;&R^VQW^CK;O68W(^L?5CNQ:QT7!/%N0P69;QIJS$)]##;_
M`.&?6N_[K5HU^#AXESNLY=++^I`>G5:2]VT'39CLN?8S&_X7T/3WHE>3U$T.
MO86WW.&RK'`:&"P_GOOK=8YM-?\`A?S_`/KGIL4OWF'NQQ",CDD.,CT_JX]\
MGJ6&)())J(_=WDT.G?;\;ZT6=/9GWY^(S$];+&1Z;C5<]^W%;6^BNGT_6J9>
M_P!']Q=$J/2>ELZ=0\.L.1E9#S=EY3A#K;3HY^T?S=;&M]*BG_`TL96KRG1$
M4%))*CG]39AN;6UOJ6N$[9@`>94>;-CPP.3)+A@.J\`DT&\DLNGK)]8595)H
MF/<9TGC<UX;[?Y2N9MF373NQ6"RR0-I\._=JCQ\YAR8YY,9,QC^>(C+W(_\`
M4_F48D&CU;"2%C.M?0QUS=EI'O;X'\453QEQ1$A8X@#KH=4*26=U_)ZKB],L
MNZ10,K-:Y@92X2""X"S\^KZ+/Y:GT3(ZCD]+HOZI2,;->#ZU($!I#G!OYUGY
MFW\]%'%ZN'7:_!O)*KU3,.!TW*S@SU#C4ON%<[=VQI?MW>[;NVJA]5NONZ_T
MY^:Z@8Q9<ZK8'[YVACMV[:S_`$B2#,"0C?J(MV4DDDES_]#U5!RP?L[XT($R
M#'&OTMU?_5HRP^M]4R[,IG0>CN#>I7MWWY)&YN)0?:<FQOY^19]##Q_\)9^D
ML_15ILX\<91_>!C_`(R#*M4&[JCV9&-TEU;,K)M:'9-A#A140[U,QC-S_M5S
M/H54^I_/?SWZ-0L;MZCLDN+;6M+G<D@M;O=$>Y_TEK6=(;86/.1=ZK`!ZA=K
M/=W'LW?\'[%CV5N&<:M[G.%H;ZA^E,@;_P"LN=Y^&;#AP89P'##,3CR"0_6<
M4C/Y?T?F9H4297N-NSJ];>TLHJD2ZP.@F-!W[?O*WA2:`XF=Q)!G=I_6WW?]
M6J]/2JFVFYV1;;8-"[?!_JN<WW_]):"U^7P93S&3F,L?;,P(1QWQ^F/64EA(
MH`:J7!9_4_K"_P"OMW2>GYQI98T,K;:`^JN<=MUMS:=/4M9M>^ECW^GZW\Y^
MC7>KSRVVJG_&MOM>VMDM;N<0!N=B;&-EWYSWG8Q7AU\FMS!(&.C5Y(@^27I'
M4.N]'^N8Z'U#.LZACY&F^W7Z5;KZ;JV_X%VZMU-E6[TETO5J+Z<MN=6W>QNT
MGN&EO[_\ARY;-L9D?XT<84D/](L8^-8<RFZRQO\`8:_W+LLCJOV?,&/97MKT
M)MG\TCZ0;'YK_I*E\3CAEAB,TSBN4>#(!?!E_0E+^JOY4FY@>H1E(#^ZPIR>
MG=2<P7U@7-G:QW!GG:?HO1>KVVTX>^IQ8[<T2/!9G5FX;;6/Q'-WF2X5G0$1
ML<-OT7K0ZSN/3AN^EN;/Q5$<Q,X>=A+@.;%$7S&'T^[<?09&/Z<6Q0N)Z'H7
M*^L]W4V_5/[;A9-E.3C[+7V5D;G,G9:UWM=[=K_4_P"MK,SOK1F#Z@8N=7>Y
MF?>YF,;P1O#ZW.]:SCZ5E5#O^W5U5.+7F=%^R6_S>12ZI_P>"QW_`%2\FQ*L
MO+?A_5FUI;MSG"SQ#G;<?)]O_`LINL6MRNN#$3J>"!)/]UI<U*4)FB?U@,!_
M?M[;J&7UC!_Q?U9;\NW]H/%5CLB1O'JV-?L^C^;59Z7T5;Z9UK+H^H8ZO?8<
MC+KHM>'V:[GA]C*O4V[/;NV*7^,$`?57(`$`/I``_P",8LW'8Y_^*UP:)(QK
M''X-M>]W_1:INGU43*.20!/IQ?\`.<KI[?K3G_5SJ76+.JFVAU=U=N)>W>U]
M88?M#ZRW;]EL;[OL_I,V?Z1;/^+JRRGZK9=M59OLKR+G,I:0"]PKJ<VMKG>W
M<_Z*I?5_+QF_XNNI,?:QCF-R:W!Q`.ZQI]%FOYUN[]'^^B_4OJ(Z7]2NH=0+
M/4./?:]K/%VRD,:?Y._Z21Z^;'CH2QRL_P`W*1-VUWX/U_S,7,ZKG9]G378S
M765XC2&M<&#U'M9Z#G-96UOLK??Z]EG^$6]]0^NYO6>DV.SG>ID8UIJ-L!I>
MTM;8QSVM]OJ>[:[:N8QL;]O]'S?K!]8NI&UM'J-Q\,/].EEK6_HIJ!^F]^WT
M:OYRS\^R[U%K?XK9_9>;//V@3_VVQ([)Q2/NPHGAG$GU&S+^L__1])ZQU%O2
M^EY74'-WC%J=9L'YQ:/:S^TY5/JWTFWIV$;<QWJ]4SG?:.H7F)=:X?S3?^!Q
MF_H*&?02^L-?6/1JR.E.H<^@N^T8V4=M5M+F[;&N?^8ZOVO:J@J^N^>-MMV'
MT>D\F@.RK_DZ_P!+&9_F6HL9/JV)K;LZW4>K=/Z94VS.N;5ZAVU,U=98Z0/3
MQZ*]UU]GN^A4Q<XY]N5EF_*#L*BRP.&*'?K!!/TLRZN6X?M_[2XSOM/^EOJ_
MFUI]*Z9]7^G=1=6W(;E];>V;;<FYMN861^ZX[Z:=OYE-=52U1]CC3TX\MJJ<
MWRQSB(CP"4#Q1EDC[G"?ZL/E_P`=?$G]+0?NQ_[J3+'=CNJ`QBPU-T&P@@?Y
MJ*HU^GM_1QM_DQ$_)25F/%0XJXNM;)\E+SC,Q<3._P`:%F%F5MNHO;MLJ?J"
M/LF[_HQN:O1T#]1^U?X+[5_9]3C_`+<_FTX&F/+CX^'^K(3_`,5RNB?4[HG1
M,IV7AL>Z\@M8ZUV_8T_2;3QMW?O_`,XM7)P\?*:&W-G;]%PT(^!1TDR<(Y(F
M,XB<3O&0L+XQ$!41P^32Q^DX=#Q8UI>YIEI>9@^,*QDXU637Z5H);(.AC4(J
M2CARV&$#CCCC&$OFB!I+^\NLW=L*:F4U-J9]!@@3JLJCZJ=&Q^LNZU56X9KG
M/L)WN+-U@V6.%?T?=[O\];"2EB!$",10`H`=EIB#1(NC8:?5>EXG5L)^#F!S
MJ+"TN#7%IEI#V^YO\IJ6#TK"P>FLZ92S=B,:YGIV'?+7ESGM?O\`I[MZN)(J
MX1=UK57X/-8_^+SZLX][[A2^PN:YM;+'ES:P\%GZ&?SFM=^C?9ZGIK2Z=]7.
ME=.Z;=TNBLNP\@O-M=CB_=ZC178-SO=]!JTTDK*T8X#:(#S.+_B[^K./<ZXT
MOO)!:QMSR]K-P+?8/;[FM=[/4WK4Z)T#IW0Z;*<`/:RYP>_>\O.X`,_._JK2
M22M4<<(ZB(%/_]G_[1&R4&AO=&]S:&]P(#,N,``X0DE-!"4``````!``````
M````````````````.$))30/M```````0`$@````!``$`2`````$``3A"24T$
M)@``````#@`````````````_@```.$))300-```````$````>#A"24T$&0``
M````!````!XX0DE-`_,```````D```````````$`.$))300*```````!```X
M0DE-)Q````````H``0`````````".$))30/U``````!(`"]F9@`!`&QF9@`&
M```````!`"]F9@`!`*&9F@`&```````!`#(````!`%H````&```````!`#4`
M```!`"T````&```````!.$))30/X``````!P``#_____________________
M________`^@`````_____________________________P/H`````/______
M______________________\#Z`````#_____________________________
M`^@``#A"24T$`````````@`!.$))300"```````$`````#A"24T$"```````
M$`````$```)````"0``````X0DE-!!X```````0`````.$))300:``````-)
M````!@``````````````-0```+0````*`%4`;@!T`&D`=`!L`&4`9``M`#$`
M```!``````````````````````````$``````````````+0````U````````
M``````````````$`````````````````````````$`````$```````!N=6QL
M`````@````9B;W5N9'-/8FIC`````0```````%)C=#$````$`````%1O<"!L
M;VYG``````````!,969T;&]N9P``````````0G1O;6QO;F<````U`````%)G
M:'1L;VYG````M`````9S;&EC97-6;$QS`````4]B:F,````!```````%<VQI
M8V4````2````!W-L:6-E241L;VYG``````````=G<F]U<$E$;&]N9P``````
M```&;W)I9VEN96YU;0````Q%4VQI8V5/<FEG:6X````-875T;T=E;F5R871E
M9`````!4>7!E96YU;0````I%4VQI8V54>7!E`````$EM9R`````&8F]U;F1S
M3V)J8P````$```````!28W0Q````!`````!4;W`@;&]N9P``````````3&5F
M=&QO;F<``````````$)T;VUL;VYG````-0````!29VAT;&]N9P```+0````#
M=7)L5$585`````$```````!N=6QL5$585`````$```````!-<V=E5$585```
M``$```````9A;'1486=415A4`````0``````#F-E;&Q497AT27-(5$U,8F]O
M;`$````(8V5L;%1E>'1415A4`````0``````"6AO<GI!;&EG;F5N=6T````/
M15-L:6-E2&]R>D%L:6=N````!V1E9F%U;'0````)=F5R=$%L:6=N96YU;0``
M``]%4VQI8V5697)T06QI9VX````'9&5F875L=`````MB9T-O;&]R5'EP965N
M=6T````115-L:6-E0D=#;VQO<E1Y<&4`````3F]N90````ET;W!/=71S971L
M;VYG``````````IL969T3W5T<V5T;&]N9P`````````,8F]T=&]M3W5T<V5T
M;&]N9P`````````+<FEG:'1/=71S971L;VYG```````X0DE-!"@```````P`
M```!/_`````````X0DE-!!0```````0````".$))300,``````O=`````0``
M`*`````O```!X```6"````O!`!@``?_8_^``$$I&248``0(!`$@`2```_^T`
M#$%D;V)E7T--``'_[@`.061O8F4`9(`````!_]L`A``,"`@("0@,"0D,$0L*
M"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,`0T+"PT.#1`.#A`4#@X.%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`S_P``1"``O`*`#`2(``A$!`Q$!
M_]T`!``*_\0!/P```04!`0$!`0$``````````P`!`@0%!@<("0H+`0`!!0$!
M`0$!`0`````````!``(#!`4&!P@)"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#
M!"$2,05!46$3(G&!,@84D:&Q0B,D%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#
M)D235&1%PJ-T-A?25>)E\K.$P]-UX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6
MIK;&UN;V-T=79W>'EZ>WQ]?G]Q$``@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($
M05%A<2(3!3*!D12AL4(CP5+1\#,D8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$
MDU2C%V1%539T9>+RLX3#TW7C\T:4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F
M]B<W1U=G=X>7I[?'_]H`#`,!``(1`Q$`/P#U5))5,\Y-;!;3:*VLY8X-@D_1
MW/L<S8F9<GMP,^$RX=2(UQ5_A<*0+--M)4\7,MS,0OJVLO:=K@Z7-D?U2/:Y
MJH/ZMGLR#0147A^R8=$SM_>5;+\1P8X8\AXC#+\DHQNS^[_>2($V.SH]0ZG@
M=,QSDY][:*IV@NY<X\5UL;+[;'?Z.MN]9C<CZQ]6.[%K'1<$\6Y#!9EO&FK,
M0GT,-O\`X9]:[_NM6C7X.'B7.ZSETLOZD!Z=5I+W;0=-F.RY]C,;_A?0]/>B
M5Y/430Z]A;?<X;*L<!H8+#^>^^MUCFTU_P"%_/\`^N>FQ2_>8>['$(R.20XR
M/3^KCWR>I88D@DFHC]W>30Z=]OQOK19T]F??GXC,3ULL9'IN-5SW[<5M;Z*Z
M?3]:IE[_`$?W%T2H])Z6SIU#PZPY&5D/-V7E.$.MM.CG[1_-UL:WTJ*?\#2Q
ME:O*=$104DDJ.?U-F&YM;6^I:X3MF`!YE1YLV/#`Y,DN&`ZKP"30;R2RZ>LG
MUA5E4FB8]QG2>-S7AOM_E*YFV9-=.[%8++)`VGP[]VJ/'SF')CGDQDS&/YXB
M,O<C_P!3^91B0:/5L)(6,ZU]#'7-V6D>]O@?Q15/&7%$2%CB`.NAU0I)9W7\
MGJN+TRR[I%`RLUKF!E+A((+@+/SZOHL_EJ?1,CJ.3TNB_JE(QLUX/K4@0&D.
M<&_G6?F;?ST4<7JX==K\&\DJO5,PX'3<K.#/4.-2^X5SMW;&E^W=[MN[:J'U
M6Z^[K_3GYKJ!C%ESJM@?OG:&.W;MK/\`2)(,P)"-^HBW922227/_T/54'+!^
MSOC0@3(,<:_2W5_]6C+#ZWU3+LRF=!Z.X-ZE>W??DD;FXE!]IR;&_GY%GT,/
M'_PEGZ2S]%6FSCQQE']X&/\`C(,JU0;NJ/9D8W275LRLFUH=DV$.%%1#O4S&
M,W/^U7,^A53ZG\]_/?HU"QNWJ.R2XMM:TN=R2"UN]T1[G_26M9TAMA8\Y%WJ
ML`'J%VL]W<>S=_P?L6/96X9QJWN<X6AOJ'Z4R!O_`*RYWGX9L.'!AG`<,,Q.
M/()#]9Q2,_E_1^9FA1)E>XV[.KUM[2RBJ1+K`Z"8T'?M^\K>%)H#B9W$D&=V
MG];?=_U:KT]*J;:;G9%MM@T+M\'^JYS??_TEH+7Y?!E/,9.8RQ]LS`A''?'Z
M8]926$B@!JI<%G]3^L+_`*^W=)Z?G&EEC0RMMH#ZJYQVW6W-IT]2UFU[Z6/?
MZ?K?SGZ-=ZO/+;:J?\:V^U[:V2UNYQ`&YV)L8V7?G/>=C%>'7R:W,$@8Z-7D
MB#Y)>D=0Z[T?ZYCH?4,ZSJ&/D:;[=?I5NOINK;_@7;JW4V5;O272]6HOIRVY
MU;=[&[2>X:6_O_R'+ELVQF1_C1QA20_TBQCXUAS*;K+&_P!AK_<NRR.J_9\P
M8]E>VO0FV?S2/I!L?FO^DJ7Q..&6&(S3.*Y1X,@%\&7]"4OZJ_E2;F!ZA&4@
M/[K"G)Z=U)S!?6!<V=K'<&>=I^B]%ZO;;3A[ZG%CMS1(\%F=6;AMM8_$<W>9
M+A6=`1&QPV_1>M#K.X].&[Z6YL_%41S$SAYV$N`YL41?,8?3[MQ]!D8_IQ;%
M"XGH>A<KZSW=3;]4_MN%DV4Y./LM?961N<R=EK7>UWMVO]3_`*VLS.^M&8/J
M!BYU=[F9][F8QO!&\/K<[UK./I654._[=754XM>9T7[);_-Y%+JG_!X+'?\`
M5+R;$JR\M^']6;6ENW.<+/$.=MQ\GV_\"RFZQ:W*ZX,1.IX($D_W6ES4I0F:
M)_6`P']^WMNH9?6,'_%_5EOR[?V@\56.R)&\>K8U^SZ/YM5GI?15OIG6LNCZ
MACJ]]AR,NNBUX?9KN>'V,J]3;L]N[8I?XP0!]5<@`0`^D`#_`(QBS<=CG_XK
M7!HDC&L<?@VU[W?]%JFZ?51,HY)`$^G%_P`YRNGM^M.?]7.I=8LZJ;:'5W5V
MXE[=[7UAA^T/K+=OV6QON^S^DS9_I%L_XNK+*?JMEVU5F^RO(N<REI`+W"NI
MS:VN=[=S_HJE]7\O&;_BZZDQ]K&.8W)K<'$`[K&GT6:_G6[OT?[Z+]2^HCI?
MU*ZAU`L]0X]]KVL\7;*0QI_D[_I)'KYL>.A+'*S_`#<I$W;7?@_7_,Q<SJN=
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MYXVVW8?1Z3R:`[*O^3K_`$L9G^9:BQD^K8FMNSK=1ZMT_IE3;,ZYM7J';4S5
MUECI`]/'HKW77V>[Z%3%SCGVY66;\H.PJ++`X8H=^L$$_2S+JY;A^W_M+C.^
MT_Z6^K^;6GTKIGU?Z=U%U;<AN7UM[9MMR;FVYA9'[KCOIIV_F4UU5+5'V.-/
M3CRVJIS?+'.(B/`)0/%&62/N<)_JP^7_`!U\2?TM!^['_NI,L=V.ZH#&+#4W
M0;""!_FHJC7Z>W]'&W^3$3\E)68\5#BKBZULGR4O.,S%Q,[_`!H68696VZB]
MNVRI^H(^R;O^C&YJ]'0/U'[5_@OM7]GU./\`MS^;3@:8\N/CX?ZLA/\`Q7*Z
M)]3NB=$RG9>&Q[KR"UCK7;]C3])M/&W=^_\`SBU<G#Q\IH;<V=OT7#0CX%'2
M3)PCDB8SB)Q.\9"POC$0%1'#Y-+'Z3AT/%C6E[FF6EYF#XPK&3C59-?I6@EL
M@Z&-0BI*.'+880....,82^:(&DO[RZS=VPIJ934VIGT&"!.JRJ/JIT;'ZR[K
M55;AFN<^PG>XLW6#98X5_1]WN_SUL)*6($0(Q%`"@!V6F(-$BZ-AI]5Z7B=6
MPGX.8'.HL+2X-<6F6D/;[F_RFI8/2L+!Z:SIE+-V(QKF>G8=\M>7.>U^_P"G
MNWJXDBKA%W6M5?@\UC_XO/JSCWON%+["YKFULL>7-K#P6?H9_.:UWZ-]GJ>F
MM+IWU<Z5T[IMW2Z*R[#R"\VUV.+]WJ-%=@W.]WT&K322LK1C@-H@/,XO^+OZ
MLX]SKC2^\D%K&W/+VLW`M]@]ON:UWL]3>M3HG0.G=#ILIP`]K+G![][R\[@`
MS\[^JM))*U1QPCJ(@4__V0`X0DE-!"$``````%,````!`0````\`00!D`&\`
M8@!E`"``4`!H`&\`=`!O`',`:`!O`'`````2`$$`9`!O`&(`90`@`%``:`!O
M`'0`;P!S`&@`;P!P`"``0P!3`````0`X0DE-!`8```````<`!`````$!`/_A
M%_EH='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O`#P_>'!A8VME="!B96=I
M;CTG[[N_)R!I9#TG5S5-,$UP0V5H:4AZ<F53>DY48WIK8SED)S\^"CQX.GAM
M<&UE=&$@>&UL;G,Z>#TG861O8F4Z;G,Z;65T82\G('@Z>&UP=&L])UA-4"!T
M;V]L:VET(#,N,"TR."P@9G)A;65W;W)K(#$N-B<^"CQR9&8Z4D1&('AM;&YS
M.G)D9CTG:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M<WEN=&%X
M+6YS(R<@>&UL;G,Z:5@])VAT='`Z+R]N<RYA9&]B92YC;VTO:5@O,2XP+R<^
M"@H@/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70])W5U:60Z869D-V5E-6$M
M8S)C92TQ,61A+6$W-6,M.#0Y9#@Q-6%C,V-C)PH@('AM;&YS.F5X:68])VAT
M='`Z+R]N<RYA9&]B92YC;VTO97AI9B\Q+C`O)SX*("`\97AI9CI#;VQO<E-P
M86-E/C$\+V5X:68Z0V]L;W)3<&%C93X*("`\97AI9CI0:7AE;%A$:6UE;G-I
M;VX^,3@P/"]E>&EF.E!I>&5L6$1I;65N<VEO;CX*("`\97AI9CI0:7AE;%E$
M:6UE;G-I;VX^-3,\+V5X:68Z4&EX96Q91&EM96YS:6]N/@H@/"]R9&8Z1&5S
M8W)I<'1I;VX^"@H@/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70])W5U:60Z
M869D-V5E-6$M8S)C92TQ,61A+6$W-6,M.#0Y9#@Q-6%C,V-C)PH@('AM;&YS
M.G!D9CTG:'1T<#HO+VYS+F%D;V)E+F-O;2]P9&8O,2XS+R<^"B`\+W)D9CI$
M97-C<FEP=&EO;CX*"B`\<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TG=75I
M9#IA9F0W964U82UC,F-E+3$Q9&$M83<U8RTX-#ED.#$U86,S8V,G"B`@>&UL
M;G,Z<&AO=&]S:&]P/2=H='1P.B\O;G,N861O8F4N8V]M+W!H;W1O<VAO<"\Q
M+C`O)SX*("`\<&AO=&]S:&]P.DAI<W1O<GD^/"]P:&]T;W-H;W`Z2&ES=&]R
M>3X*(#PO<F1F.D1E<V-R:7!T:6]N/@H*(#QR9&8Z1&5S8W)I<'1I;VX@<F1F
M.F%B;W5T/2=U=6ED.F%F9#=E935A+6,R8V4M,3%D82UA-S5C+3@T.60X,35A
M8S-C8R<*("!X;6QN<SIT:69F/2=H='1P.B\O;G,N861O8F4N8V]M+W1I9F8O
M,2XP+R<^"B`@/'1I9F8Z3W)I96YT871I;VX^,3PO=&EF9CI/<FEE;G1A=&EO
M;CX*("`\=&EF9CI84F5S;VQU=&EO;CXW,B\Q/"]T:69F.EA297-O;'5T:6]N
M/@H@(#QT:69F.EE297-O;'5T:6]N/C<R+S$\+W1I9F8Z65)E<V]L=71I;VX^
M"B`@/'1I9F8Z4F5S;VQU=&EO;E5N:70^,CPO=&EF9CI297-O;'5T:6]N56YI
M=#X*(#PO<F1F.D1E<V-R:7!T:6]N/@H*(#QR9&8Z1&5S8W)I<'1I;VX@<F1F
M.F%B;W5T/2=U=6ED.F%F9#=E935A+6,R8V4M,3%D82UA-S5C+3@T.60X,35A
M8S-C8R<*("!X;6QN<SIX87`])VAT='`Z+R]N<RYA9&]B92YC;VTO>&%P+S$N
M,"\G/@H@(#QX87`Z0W)E871E1&%T93XR,#`V+3`T+3`S5#`Q.C`Q.C,U+3`U
M.C`P/"]X87`Z0W)E871E1&%T93X*("`\>&%P.DUO9&EF>41A=&4^,C`P-BTP
M-"TP,U0P,3HP,3HS-2TP-3HP,#PO>&%P.DUO9&EF>41A=&4^"B`@/'AA<#I-
M971A9&%T841A=&4^,C`P-BTP-"TP,U0P,3HP,3HS-2TP-3HP,#PO>&%P.DUE
M=&%D871A1&%T93X*("`\>&%P.D-R96%T;W)4;V]L/D%D;V)E(%!H;W1O<VAO
M<"!#4R!7:6YD;W=S/"]X87`Z0W)E871O<E1O;VP^"B`\+W)D9CI$97-C<FEP
M=&EO;CX*"B`\<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TG=75I9#IA9F0W
M964U82UC,F-E+3$Q9&$M83<U8RTX-#ED.#$U86,S8V,G"B`@>&UL;G,Z>&%P
M34T])VAT='`Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]M;2\G/@H@(#QX87!-
M33I$;V-U;65N=$E$/F%D;V)E.F1O8VED.G!H;W1O<VAO<#IA9F0W964U.2UC
M,F-E+3$Q9&$M83<U8RTX-#ED.#$U86,S8V,\+WAA<$U-.D1O8W5M96YT240^
M"B`\+W)D9CI$97-C<FEP=&EO;CX*"B`\<F1F.D1E<V-R:7!T:6]N(')D9CIA
M8F]U=#TG=75I9#IA9F0W964U82UC,F-E+3$Q9&$M83<U8RTX-#ED.#$U86,S
M8V,G"B`@>&UL;G,Z9&,])VAT='`Z+R]P=7)L+F]R9R]D8R]E;&5M96YT<R\Q
M+C$O)SX*("`\9&,Z9F]R;6%T/FEM86=E+VIP96<\+V1C.F9O<FUA=#X*(#PO
M<F1F.D1E<V-R:7!T:6]N/@H*/"]R9&8Z4D1&/@H\+W@Z>&UP;65T83X*("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@(`H@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@"B`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`*("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@(`H@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@"CP_
M>'!A8VME="!E;F0])W<G/S[_X@Q824-#7U!23T9)3$4``0$```Q(3&EN;P(0
M``!M;G1R4D="(%A96B`'S@`"``D`!@`Q``!A8W-P35-&5`````!)14,@<U)'
M0@``````````````````]M8``0````#3+4A0("``````````````````````
M`````````````````````````````````````````!%C<')T```!4````#-D
M97-C```!A````&QW='!T```!\````!1B:W!T```"!````!1R6%E:```"&```
M`!1G6%E:```"+````!1B6%E:```"0````!1D;6YD```"5````'!D;61D```"
MQ````(AV=65D```#3````(9V:65W```#U````"1L=6UI```#^````!1M96%S
M```$#````"1T96-H```$,`````QR5%)#```$/```"`QG5%)#```$/```"`QB
M5%)#```$/```"`QT97AT`````$-O<'ER:6=H="`H8RD@,3DY."!(97=L971T
M+5!A8VMA<F0@0V]M<&%N>0``9&5S8P`````````2<U)'0B!)14,V,3DV-BTR
M+C$``````````````!)S4D="($E%0S8Q.38V+3(N,0``````````````````
M````````````````````````````````````````````````6%E:(```````
M`/-1``$````!%LQ865H@`````````````````````%A96B````````!OH@``
M./4```.06%E:(````````&*9``"WA0``&-I865H@````````)*````^$``"V
MSV1E<V,`````````%DE%0R!H='1P.B\O=W=W+FEE8RYC:```````````````
M%DE%0R!H='1P.B\O=W=W+FEE8RYC:```````````````````````````````
M``````````````````````````````!D97-C`````````"Y)14,@-C$Y-C8M
M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92`M('-21T(`````````````
M`"Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92`M('-2
M1T(`````````````````````````````9&5S8P`````````L4F5F97)E;F-E
M(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0``````````````
M+%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$`
M`````````````````````````````````'9I97<``````!.D_@`47RX`$,\4
M``/MS``$$PL``UR>`````5A96B```````$P)5@!0````5Q_G;65A<P``````
M```!`````````````````````````H\````"<VEG(`````!#4E0@8W5R=@``
M``````0`````!0`*``\`%``9`!X`(P`H`"T`,@`W`#L`0`!%`$H`3P!4`%D`
M7@!C`&@`;0!R`'<`?`"!`(8`BP"0`)4`F@"?`*0`J0"N`+(`MP"\`,$`Q@#+
M`-``U0#;`.``Y0#K`/``]@#[`0$!!P$-`1,!&0$?`24!*P$R`3@!/@%%`4P!
M4@%9`6`!9P%N`74!?`&#`8L!D@&:`:$!J0&Q`;D!P0')`=$!V0'A`>D!\@'Z
M`@,"#`(4`AT")@(O`C@"00)+`E0"70)G`G$">@*$`HX"F`*B`JP"M@+!`LL"
MU0+@`NL"]0,``PL#%@,A`RT#.`-#`T\#6@-F`W(#?@.*`Y8#H@.N`[H#QP/3
M`^`#[`/Y!`8$$P0@!"T$.P1(!%4$8P1Q!'X$C`2:!*@$M@3$!-,$X03P!/X%
M#04<!2L%.@5)!5@%9P5W!88%E@6F!;4%Q075!>4%]@8&!A8&)P8W!D@&609J
M!GL&C`:=!J\&P`;1!N,&]0<'!QD'*P<]!T\'80=T!X8'F0>L![\'T@?E!_@(
M"P@?"#((1@A:"&X(@@B6"*H(O@C2".<(^PD0"24).@E/"60)>0F/":0)N@G/
M">4)^PH1"B<*/0I4"FH*@0J8"JX*Q0K<"O,+"PLB"SD+40MI"X`+F`NP"\@+
MX0OY#!(,*@Q##%P,=0R.#*<,P`S9#/,-#0TF#4`-6@UT#8X-J0W##=X-^`X3
M#BX.20YD#G\.FPZV#M(.[@\)#R4/00]>#WH/E@^S#\\/[!`)$"800Q!A$'X0
MFQ"Y$-<0]1$3$3$13Q%M$8P1JA')$>@2!Q(F$D429!*$$J,2PQ+C$P,3(Q-#
M$V,3@Q.D$\43Y10&%"<4211J%(L4K13.%/`5$A4T%585>!6;%;T5X!8#%B86
M219L%H\6LA;6%OH7'1=!%V47B1>N%](7]Q@;&$`891B*&*\8U1CZ&2`911EK
M&9$9MQG=&@0:*AI1&G<:GAK%&NP;%!L[&V,;BANR&]H<`APJ'%(<>QRC',P<
M]1T>'4<=<!V9'<,=[!X6'D`>:AZ4'KX>Z1\3'SX?:1^4'[\?ZB`5($$@;""8
M(,0@\"$<(4@A=2&A(<XA^R(G(E4B@B*O(MTC"B,X(V8CE"/"(_`D'R1-)'PD
MJR3:)0DE."5H)9<EQR7W)B<F5R:')K<FZ"<8)TDG>B>K)]PH#2@_*'$HHBC4
M*08I."EK*9TIT"H"*C4J:"J;*L\K`BLV*VDKG2O1+`4L.2QN+*(LURT,+4$M
M=BVK+>$N%BY,+H(NMR[N+R0O6B^1+\<O_C`U,&PPI##;,1(Q2C&",;HQ\C(J
M,F,RFS+4,PTS1C-_,[@S\30K-&4TGC38-1,U336'-<(U_38W-G(VKC;I-R0W
M8#><-]<X%#A0.(PXR#D%.4(Y?SF\.?DZ-CIT.K(Z[SLM.VL[JCOH/"<\93RD
M/.,](CUA/:$]X#X@/F`^H#[@/R$_83^B/^)`(T!D0*9`YT$I06I!K$'N0C!"
M<D*U0O=#.D-]0\!$`T1'1(I$SD42155%FD7>1B)&9T:K1O!'-4=[1\!(!4A+
M2)%(UTD=26-)J4GP2C=*?4K$2PQ+4TN:2^),*DQR3+I-`DU*39--W$XE3FY.
MMT\`3TE/DT_=4"=0<5"[40914%&;4>92,5)\4L=3$U-?4ZI3]E1"5(]4VU4H
M5755PE8/5EQ6J5;W5T17DE?@6"]8?5C+61I9:5FX6@=:5EJF6O5;15N56^5<
M-5R&7-9=)UUX7<E>&EYL7KU?#U]A7[-@!6!78*I@_&%/8:)A]6))8IQB\&-#
M8Y=CZV1`9)1DZ64]99)EYV8]9I)FZ&<]9Y-GZ6@_:)9H[&E#:9II\6I(:I]J
M]VM/:Z=K_VQ7;*]M"&U@;;EN$FYK;L1O'F]X;]%P*W"&<.!Q.G&5<?!R2W*F
M<P%S77.X=!1T<'3,=2AUA77A=CYVFW;X=U9WLW@1>&YXS'DJ>8EYYWI&>J5[
M!'MC>\)\(7R!?.%]07VA?@%^8G["?R-_A'_E@$>`J($*@6N!S8(P@I*"](-7
M@[J$'82`A..%1X6KA@Z&<H;7ASN'GX@$B&F(SHDSB9F)_HIDBLJ+,(N6B_R,
M8XS*C3&-F(W_CF:.SH\VCYZ0!I!ND-:1/Y&HDA&2>I+CDTV3MI0@E(J4])5?
ME<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY`GJZ?
M'9^+G_J@::#8H4>AMJ(FHI:C!J-VH^:D5J3'I3BEJ:8:IHNF_:=NI^"H4JC$
MJ3>IJ:H<JH^K`JMUJ^FL7*S0K42MN*XMKJ&O%J^+L`"P=;#JL6"QUK)+LL*S
M.+.NM"6TG+43M8JV`;9YMO"W:+?@N%FXT;E*N<*Z.[JUNRZ[I[PAO)N]%;V/
MO@J^A+[_OWJ_]<!PP.S!9\'CPE_"V\-8P]3$4<3.Q4O%R,9&QL/'0<>_R#W(
MO,DZR;G*.,JWRS;+MLPUS+7--<VUSC;.ML\WS[C0.="ZT3S1OM(_TL'31-/&
MU$G4R]5.U='65=;8UUS7X-ADV.C9;-GQVG;:^]N`W`7<BMT0W9;>'-ZBWRG?
MK^`VX+WA1.',XE/BV^-CX^OD<^3\Y83F#>:6YQ_GJ>@RZ+SI1NG0ZEOJY>MP
MZ_OLANT1[9SN*.ZT[T#OS/!8\.7Q<O'_\HSS&?.G]#3TPO50]=[V;?;[]XKX
M&?BH^3CYQ_I7^N?[=_P'_)C]*?VZ_DO^W/]M____[@`.061O8F4`9``````!
M_]L`A``&!`0$!00&!04&"08%!@D+"`8&"`L,"@H+"@H,$`P,#`P,#!`,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0<'!PT,#1@0$!@4#@X.%!0.#@X.
M%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`S_
MP``1"``U`+0#`1$``A$!`Q$!_]T`!``7_\0!H@````<!`0$!`0``````````
M!`4#`@8!``<("0H+`0`"`@,!`0$!`0`````````!``(#!`4&!P@)"@L0``(!
M`P,"!`(&!P,$`@8"<P$"`Q$$``4A$C%!408382)Q@10RD:$'%;%"(\%2T>$S
M%F+P)'*"\25#-%.2HK)C<\(U1">3H[,V%U1D=,/2X@@F@PD*&!F$E$5&I+16
MTU4H&O+C\\34Y/1E=865I;7%U>7U9G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<X
M2%AH>(B8J+C(V.CX*3E)66EYB9FIN<G9Z?DJ.DI::GJ*FJJZRMKJ^A$``@(!
M`@,%!00%!@0(`P-M`0`"$0,$(1(Q0051$V$B!G&!D3*AL?`4P='A(T(54F)R
M\3,D-$."%I)3):)CLL('<](UXD2#%U23"`D*&!DF-D4:)V1T53?RH[/#*"G3
MX_.$E*2TQ-3D]&5UA96EM<75Y?5&5F9VAI:FML;6YO9'5V=WAY>GM\?7Y_<X
M2%AH>(B8J+C(V.CX.4E9:7F)F:FYR=GI^2HZ2EIJ>HJ:JKK*VNKZ_]H`#`,!
M``(1`Q$`/P#U3BKL5=BKL5=BJ0^9O.VA>7C'!=.]QJ5QM::5:*9KN8_Y$2[T
M_P`M^*?Y6$1MHRZB,-C]7\V/U)1%;?F5KP]:YNX?*EB_]W:6Z)>7Q!_W[-)6
M")O\F..3_7P[!J`S3YGPA_IYJ?Y<:CY@EU;S/I>H:@VK6&CW<=M8ZC*B)*SF
M/G-&YC"HWI,56M,,D:6<S*42>*,3Z9?[IG.0<UV*NQ5V*NQ5V*NQ5V*NQ5V*
MNQ5V*NQ5V*NQ5__0]4XJA=1FO8;?U+2-)'4U<2,5`0`DFHKF'KLN;'CXL0C,
MCZN,\'H91`)W0FC>8(=1DDMV3TKJ+<I7DK+TY(U!49@=E=M0U4C`C@RP_AOB
MC./\_')E/'P[]$-J7F>XTYZ7.G.J,Q$<GJ*0U.^U:9B:_P!H,FE/[S#(1)/!
M+CCZ^%E#$)<BAQK.H:[:26VGQSV',B-]0A:%GBKU*B566M/\ELGV=V_/5GT8
M9<'%PSGQQ]'_`!3'-@VKBX2@;'2_+GDZ4Q:?`UYK5Y\5[J5W(9+B2O[4T[`M
M3_(7BG^3F1VKV['33&,#CRR\^"&./\Z<FG3:.,18_P!-_'),-7U77SIR6-C#
M&NOWY*6Q!+Q6\6W*ZE.WPQ@_"G^[).$>;'0SRSQ\641A+^@>+T_PL=1(CTP^
MJ7^Q_I)AY9\N6'EW1H-+LN3)'5Y9Y#62:5SRDED;]IY&/)LRR;7%B$(\(33`
MV.Q50O;ZULH#/<R".,;5.Y)\`!U.8VKUF+3PX\AX8LHQ)-!)T\[:*TG$^JJ_
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MT97D7)=BKL5?_]'U3BK3@E&`ZD$9&8L$*PBWF^J^8K2>5RB<']9WY#X55JDE
MI)30?ZV>>:0RAVEB.]S]/JXOZ4?X\N?_`'3ESK@*77_FL>9M._2%M:20:0MR
M8],NY1Q-V@3XYD0_$L7/X8R?M_:S8^VHK'C_`*TON#C:#-XED#T_P_TF1>0O
M]X+G_C+_`,:C)^QG]Q/_`(9_O0W:CF$OE,DWF34'!;DK",%>50!1:?#)$>V:
MK*93[0S2%V#P;<7]7^#+@_F_TF8V@&:K%&K,X4!V`#-W(7IOGHP<2EV*O(+K
M\^+RU\ZZGY<.A/>&SEFM[);1FDGN)HS2->'&BANKM\7!<L\/:W5'M(C(8<-T
MM\J_GGJ]SYTB\L^9]$&DS7,@@BHS\XY7%8UD5Q\0DJ`'7^;"<>UA&'M&1R<$
MX\+,O/PF_P!#._H_'\N6W\,\^]M1/]W_`#/5_I_2]!INJM::7H&K:,D-H$CN
MT1>3T_>*XZEN[`YD:7L[0Z[2"&+AAF$1ZO\`*QR?Q<?\Z/\`L6,IRC+?DG6B
M:4=,L_JWK&8<BP)%`*]0!OMG0=D]F_D\/A\7B;\7\UJR3XC:7V6O>OY@ET_Z
MLB<&D7U@?B/#Z.^:S2=L^)KI8.",>$S_`'G\7H9RQU&[8EJ7YMWVF?FC!Y-O
M--B2SN98HX=0$K<BLZ5C/`K3^\_=_:SJA#:W43UQCF\,C8_Q*GYJ?FU=>3-4
MTW3+'3DU&[OT:0H\ACXU<)&!16KS;E_P.,86G6:TX9"('$9*OYM?F!-Y/TC2
M[J72K?49KR1HY(9FHL;+'R/$\6KOMC"-IUNI\*()'%;)+;S19P>1H/,U[&+:
MU&GI?2PQ[A`8A)P3I7KQ7(UO3D1S`8A,\N'B>6:3^?/F368]0G;RK++H,*.E
MQ=67.:2W#*:&2H"/MNU.'%?BRPXP'68^TISL\'H_HI=_SBU_O?YA_P",-K_Q
M*7#E:^QN<O@RGSQ^><VE^9'\M>6=);6=4A?TIF^,KZH%6CCCC!>0I^V?AXY&
M,-K+E:CM'AGP0'')WD+\\KG6/,R^6O,>DG2=3E8QPLI<#U0.7IR1R`/&6`^$
MU;&6.A81INT3.?!,<,GK65NU?__2]4XJIW-S;VUO)<W$BPP0J9)97(55514L
MQ/0`8H)`%E@-K<IYBTY-=T*SN#:&:06KRI'%S56IS6,*&DAD_89FY?S+G%]L
M]CYL>09<$3.4)>)'@\./A_T?#CCA.?\`RLFV:;4QRQOI_2_B7>8-1N;BSM+>
M?3VL?0)"BA5"`H%$!`H!X9I.W^TLVHQPCEQ2PRB3]7%PS_J\0_XIR<.,1Y%?
MY<U:_L[.>&SL7NI)'J)%!*J>(&]!_')=A=IY\&&4,6*6:4I?5ZN"'I_BX1_O
MHIRP!.Y37R_H=T9&N;^)HY'?U'YF-N;5K]DHS(/]GFZ[%['RF1R9XF,I2\27
M'X<_$G_4\.4\?_*R+5DR#D&49V;CNQ5\Z>3O_6E-1_YBM0_Y-OETOI>?P?XX
M??+_`'S7YNJJ?GIH3H.+,VFLQ'<BY(K]PPP^E==_C,?\W_=/H/4(]/FMVAOB
MGHMU$A"[]B":;YK-=#!/&89N'@E_//"]%$D'9B&L^5[C3`;_`$^9C%%\1WI(
M@\01]H9PG:OL[/1CQ\$CP0W_`-MQ_P"=_$Y4,HEL60>5]7EU*P+3[SPMPD8;
M<MJALZCV=[4EJ\%S_O,9X)?TOYLFC-#A.R1:1_RFUQ_QDG_CG-]F?\;$_P"M
ME_2W3_NP\Z_YR3TV6QU;R_YIMA26)C`[`?MPMZ\-?^2F>DXST>8[6APRC,)<
M;F'SW^?UA+"1+IUDL$P[KPMH1.1_R/?CCRBUV,^J!_AC^/\`=)]_SE'_`,<+
M0_\`F*E_Y-8,3?VQ]$?>G7FPD?\`./`(-/\`</8C[_1&`?4W9O\`%/\`,C_O
M4%_SC^JC\K-28"A:ZN^1\:0H,.3FP[+_`+@^\_<QS_G%K_>[S#_QAM?^)2X<
MKC]C<Y?!D7F?SYY,\N>;9;+REY;BU?SI*[I-+;1A>,LGQ2*TB@O(_>4+_LY%
MR(B2-^3D9M3CQY*QQXLKSHS^9;C\]M(G\RVT-GK$E[9-/;6YJB*57TQ4,^_#
MCR^++-N'9U]S.J!F*E<7U-F.],__T_5.*O-=:DF_,'S1-Y:MG9?*.B2*?,$Z
M$CZW=*>2V:L/]UI]J?\`X'^7)C86Z_(3GGP#^[A]?]*7\QZ1##%#$D,*+'%&
MH2.-0`JJHH``.@`R#G@5LQ?S^0+2T8D!0[DD[``+U)SBO;,7CQ_UI.3I^J'_
M`"^O);FSF:UB+6;R\A>MM&X``_=#K)T^W_=_RL^9WLKHLN#!+Q!P2G+BX?X^
M'A_BC_!_G-.7,)GT[Q_G?P_YO\YF6=.Q=BKL5?+UM<^8+7\^M7N=`M([[4X;
MR^=+.5O3$J!6]1`W[+\*\/\`*R_;AW>:!F-43`<4KE^E,[#1?//GS\VK/7-5
MT2?2+.QF@><3(Z)'%:GF(P[JOJ/(X_9'[7\N)(`;8X\N?.)2CP"/^]>V^;-`
MEU!$N;4<KF$%2G3DG7:O<9QWM+V+/51&3'ODAZ>'^?#_`(J+T^')P[%)I;_S
M5<V7Z,>T<U`1Y/38.5'8L?A^G.?R:WM/-A_+''+^9*?!+CX?Z4OH_P`YM$8`
MW;(O+&CRZ98%9Z>O,W.11N%VH%KG6>SW9<M)@J?]Y,\4OZ/]%HRSXBE6F:??
M1^;I[E[>1;=GF*RE2%(-:;^^:3L_0YH]JSR&$AC,LOKX?1ZOZ39.0X*0GYS>
M6;CS#Y`OK6TA:XO[=H[JTAC')V>-J%5`ZEHV<9WD#1=3K\)R8B!S8/\`\X[^
M1-:T>^U?5M:T^:PG,<=K:)<1F-BK'G(RANWPQC)9)6X796FE`F4APIG_`,Y%
M^7M=UK1]'BTC3Y]0DAN9&E2WC:0JICH"W'IO@QFFWM7%*<1PCBW9-/Y7O=7_
M`"?B\NLA@OY=(@A$4HXE9XXE*J]?L_O%XM@OU6Y)PF6GX.O`'E7Y:7?YJZ%I
M]_Y/L_+$C/=2NPO+Q7AAMFD01NS-3A*E%#+P?_5YY9*CNZO1G/`'&(\_XI?P
MI]_SCKY6\Q:'?Z\=7TVYL4ECMU@>XC:,.4:2O'D-^HR.0@M_96&<#+B!BQ+R
M[9_F#Y`_,'4;E/+5QK4UR9H8Y5CD*2++*'$L<R*ZKRI\=?\`9<<D:(<7%'+@
MS$\)G:,7RW^95]^<.E>8-=T26+G=VDUQ);1L]O#$H4*ID'):QJ*2'E]K&QPT
MR\'-+4"<H]8OH_*'H7__U/3FKW)BM##%,D%[=AX+!I/L_6#&[I_Q`MA##(:'
MF?I2C\OO+8\L^3[#3IP$NTC];4I"P/*YE^.9F?\`:^,TY?RX9&RU:;%X>,`\
M_P"+^LE^K_FIH4-Z=*T&*3S)KAV%CIU'1#XS7']S$H_:);X?Y<1%A/61!X8_
MO)?T?^*05UY6\VZX(KOS,L%TZGG;:)`U+"`]C,6_>7LO^OQMO^*GS4]J'/0_
M+XXSR#Z<N3A_=?U(_P`]LQ83/?*=O]2C]'^?_/\`]RGN@VGF&P=DGMTDCFD5
MI)?4`*@`+L`.@`V7-/V1I^T-/(C)&.3Q9\>3)XGK_I?UG.R&!Y=&29UC0[%7
M8J\=\N?EIYLL?SHO/-=Q#$-&FGO)(Y!*I?C.C!/@Z]3EAD.&G4XM)..H,S]-
MR>Q96[9V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*NQ5V*O_]7N7YP#RT?)Y&OF[$7U
MF'ZB=.%;L7>_I^B"0O*G/[1^SDH7;AZ[@\/U7S]/#]7$\P1?)ZF+_'$GG*2Q
MVX'64DCLZ?Y0@>1\LWZ4ZW]W_E/&K_;/H>T^3?\`!GZ'3_"7U/\`1G_+EQX\
MO\OC\7/_`(R?'E1OJ[?!X?#Z*K^BGN!O=BKL5=BKL5=BKL5=BKL5=BKL5=BK
1L5=BKL5=BKL5=BKL5=BK_]D_
`
end
</TEXT>
</DOCUMENT>
</SUBMISSION>
